Document:

exv10w7

EXHIBIT 10.7

	 	 	 
	

	 	 

LICENSE AGREEMENT

     THIS LICENSE AGREEMENT (this “Agreement”) dated as of February 14, 2008 (the “Effective
Date”), is entered into between FALLBROOK TECHNOLOGIES INC., a Delaware corporation (“Fallbrook”),
having a place of business at 9444 Waples St., Suite 410, San Diego, California 92121, and VIRYD
TECHNOLOGIES INC., a Delaware corporation (“Manufacturer”), having a place of business at 9444
Waples Street, Suite 410, San Diego, California 92121.

     WHEREAS, Fallbrook owns or has rights in certain technology regarding the NuVinciTM
continuously variable transmission technology that is disclosed in the patents and patent
applications listed on Exhibit A.

     WHEREAS, Manufacturer desires to obtain an exclusive license to such technology to develop,
manufacture and sell products that utilize such technology all on the terms and conditions set
forth in this Agreement.

     NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein
contained, the parties agree as follows:

1. DEFINITIONS

     1.1 “Affiliate” shall mean, with respect to any entity, any other entity that directly
or indirectly controls, is controlled by, or is under common control with, such entity. An entity
shall be regarded as in control of another entity if it owns, or directly or indirectly controls,
at least fifty percent (50%) of the voting stock or other ownership interest of the other entity,
or if it directly or indirectly possesses the power to direct or cause the direction of the
management and policies of the other entity by any means whatsoever.

     1.2 “Confidential Information” shall mean (a) all information of any kind whatsoever,
and all tangible and intangible embodiments thereof of any kind whatsoever, that is disclosed by
Fallbrook to Manufacturer and is marked, identified as or otherwise acknowledged to be confidential
at the time of disclosure, (b) all information regarding an Improvement, or (c) the terms of this
Agreement. Notwithstanding the foregoing, Confidential Information described in clause (a) above
shall not include information which Manufacturer can establish by written documentation (i) has
been publicly known prior to disclosure of such information by Fallbrook, (ii) has become publicly
known, without fault on the part of Manufacturer, subsequent to disclosure of such information by
Fallbrook, (iii) has been received by Manufacturer at any time from a source, other than Fallbrook,
rightfully having possession of and the right to disclose such information, or (iv) has been
otherwise known by Manufacturer prior to disclosure of such information by Fallbrook.

     1.3 “Field of Use” shall mean drive trains used in wind turbines designed for the
conversion of wind energy into electrical power.

Proprietary Information

 1 of 20

 

LICENSE AGREEMENT

     1.4 “Improvement” shall mean any improvement, invention, discovery, composition,
enhancement, technology, data or information (whether or not patentable) (a) made or conceived by
employees or others on behalf of Manufacturer during the term of this Agreement and (b) arising or
resulting from the exercise of Manufacturer’s rights under this Agreement (including without
limitation any improvements, modifications or derivatives to the inventions disclosed in the
patents and patent applications listed on Exhibit A), but shall not include developments of either
party that are applicable for their intended purpose in products other than Products.

     1.5 “Licensed IP Rights” shall mean, collectively, all of Fallbrook’s rights in and to
the Licensed Patents.

     1.6 “Licensed Mark” means, collectively, (a) the trademark(s) set forth on Exhibit B,
(b) the respective stylistic marks and distinctive logotypes for such trademark(s), and (c) other
marks and logotypes as Fallbrook may from time to time designate during the course of this
Agreement.

     1.7 “Licensed Patents” shall mean (a) those certain patent applications and patents
listed on Exhibit A hereto (as such list may be amended from time to time by the parties in
writing); (b) all patent applications heretofore or hereafter filed or having legal force in any
country within the Territory that claim an Improvement; (c) all patents that have issued or in the
future issue from any of the foregoing patent applications, including utility, model and design
patents and certificates of invention; and (d) all divisionals, continuations,
continuations-in-part, reissues, renewals, extensions or additions to any of the foregoing patent
applications and patents.

     1.8 “Product” shall mean any product intended for the Field of Use and that the
making, using, selling, offering for sale or importation of such product, but for the licenses
granted hereunder, infringes the pending or issued claims of the Licensed Patents.

     1.9 “Sales Price” shall mean with respect to any Transmission Product (a) where such
Transmission Product is separately itemized or invoiced, the price Manufacturer or its Affiliate
charges its customer for such Transmission Product, or (b) where not separately itemized or
invoiced, the sum of (i) the fully burdened cost to manufacture such Transmission Product, and
(ii) an amount equal to the average profit margin Manufacturer or its Affiliate realizes with its
products and services (but in no case less than an amount equal to *** of the fully
burdened cost to manufacture such Transmission Product).

     1.10 “Shares” shall mean *** shares of Manufacturer’s Series A preferred stock.

     1.11 “System Sales Price” shall mean the Sales Price of a wind turbine product that
incorporates a Transmission Product. Notwithstanding the foregoing, System Sales Price shall
exclude the cost of labor to assemble and install the wind turbine product, other than the cost to
assemble the Transmission Product, and shall include the cost of land and the cost of permits for
the wind turbine product.

 

			
	***	 	Portions of this page have been omitted
pursuant to a request for Confidential Treatment filed separately with the
Commission.

Proprietary Information

 2 of 20

 

LICENSE AGREEMENT

     1.12 “Territory” shall mean worldwide.

     1.13 “Third Party” shall mean any person or entity other than Fallbrook or
Manufacturer.

     1.14 “Transmission” shall mean the transmission and variator portion of a product,
including (1) the control actuator, including the electromechanical or mechanical device that
mechanically, or with fluid, shifts the transmission, but not including the mechanism that
transmits signals to the control actuator, such as electronic or mechanical signal transmission
lines or cables; and in instances where the actuator and the signal transmission mechanism overlap,
then Fallbrook in its sole and reasonable discretion shall determine the termination boundary
between the transmission and the control signal transmission mechanism, (2) the case or housing of
the transmission, except, as determined by Fallbrook in its sole and reasonable discretion, that
portion of any such case or housing determined to be unassociated with the transmission, and (3) in
cases where a generator is integrated with the transmission, as determined by Fallbrook in its sole
and reasonable discretion, the generator of the wind turbine.

     1.15 “Transmission Product” shall mean a Product that consists solely of a
Transmission.

2. REPRESENTATIONS AND WARRANTIES

     Each party hereby represents and warrants to the other party as follows:

     2.1 Corporate Existence. Such party is a corporation duly organized, validly existing
and in good standing under the laws of the state in which it is incorporated.

     2.2 Authorization and Enforcement of Obligations. Such party (a) has the corporate
power and authority and the legal right to enter into this Agreement and to perform its obligations
hereunder, and (b) has taken all necessary corporate action on its part to authorize the execution
and delivery of this Agreement and the performance of its obligations hereunder. This Agreement
has been duly executed and delivered on behalf of such party, and constitutes a legal, valid,
binding obligation, enforceable against such party in accordance with its terms.

     2.3 No Consents. All necessary consents, approvals and authorizations of all
governmental authorities and other persons or entities required to be obtained by such party in
connection with this Agreement have been obtained.

     2.4 No Conflict. The execution and delivery of this Agreement and the performance of
such party’s obligations hereunder (a) do not conflict with or violate any requirement of
applicable laws or regulations, and (b) do not conflict with, or constitute a default under, any
contractual obligation of it.

Proprietary Information

 3 of 20

 

LICENSE AGREEMENT

3. LICENSE GRANT

     3.1 License Grants.

          (a) Fallbrook hereby grants to Manufacturer an exclusive, nontransferable, limited license
(without the right to grant sublicenses) under the Licensed IP Rights in the Territory and only for
the Field of Use to use, develop, make, have made and import Products; and to offer for sale and
sell or lease Products, all for any legal purpose. As used herein “have made” shall mean that
Manufacturer shall have the right to utilize a Third Party to manufacture Products solely for the
benefit, and under the direction, of Manufacturer; provided, however, that Manufacturer has first
entered into a written agreement with such Third Party that contains terms and conditions regarding
confidentiality and ownership of any intellectual property resulting from such manufacturing
substantially similar to those contained herein.

          (b) Fallbrook hereby grants to Manufacturer a royalty-free, nonexclusive, nontransferable,
limited license (without the right to grant sublicenses) in the Territory to reproduce, use and
display the Licensed Marks in connection with the developing, making, having made, offering for
sale and selling Products as set forth in Section 3.1(a) above.

          (c) If at any time during the term of this Agreement Manufacturer desires to expand the Field
of Use to include other areas of fluid energy conversion or generation, Manufacturer shall provide
to Fallbrook written notice of such desire, describing in reasonable detail such additional
field(s) of use. If such additional field(s) of use is(are) available for licensing by Fallbrook,
Fallbrook and Manufacturer shall enter into good faith negotiations for a period of ninety (90)
days (or such additional time as the parties may agree) and attempt to reach mutual agreement upon
terms and conditions to be included in an amendment to the Agreement to include such additional
field(s) of use within the Field of Use. Such good faith negotiations shall take into account
Manufacturer’s ability to research, develop and commercialize Products in the current Field of Use,
as well as Manufacturer’s then-current ability, and its ability in the future, to research, develop
and commercialize Products in such additional field(s) of use. If, following such good faith
negotiations, the parties are unable to reach agreement on such terms and conditions, Fallbrook
shall have no obligation to include such additional field(s) of use within the scope of this
Agreement.

     3.2 No Implied Licenses. Except as otherwise provided in this Agreement, under no
circumstances shall Manufacturer, as a result of this Agreement, obtain any ownership interest or
other right in any invention, discovery, composition or other technology, or in any patent right or
other intellectual property right, of Fallbrook (including without limitation those owned,
controlled or developed by Fallbrook at any time pursuant to this Agreement).

4. FEES

     4.1 License Fees. As partial consideration for the license granted under this
Agreement, Manufacturer shall issue the Shares to Fallbrook within thirty (30) days following the
Effective Date.

     4.2 Royalty Rate. Manufacturer shall pay royalties to Fallbrook in accordance with
the following:

Proprietary Information

 4 of 20

 

LICENSE AGREEMENT

          (a) with respect to the sale of Products, Manufacturer shall pay to Fallbrook a royalty equal
to the greater of (i) *** of the Sales Price of the Transmission Product, and (ii)
*** of the System Sales Price; provided, however, that such royalty shall not be due on any
Sales Price or System Sales Price that is refunded to the applicable customer; and

          (b) with respect to revenue and consideration received by Manufacturer or its Affiliates from
leases or other transactions regarding the Products (other than the sale of Products described in
Section (a) above), Manufacturer shall pay to Fallbrook a royalty equal to the greater of (i)
*** of such gross revenue and consideration, and (ii) ***
of the gross profit from such gross revenue and consideration (the “gross profit” being
calculated as the gross revenue and consideration less direct costs that Manufacturer actually
incurs and that are directly attributable to the specific revenue or consideration generating
transaction).

          (c) Royalties owing on the sale of Products shall accrue on the date upon which the applicable
payment is invoiced by, or otherwise owing, Manufacturer for such sale.

          (d) Royalties owing under Section 4.2(b) shall accrue when Manufacturer receives payment for
pertinent transactions.

     4.3 Payment Terms. Except for the License Fee under Section 4.1, payments under this
Agreement shall be made in United States dollars within thirty (30) days after the end of the
calendar month in which they accrue and shall be considered late thirty (30) days past the due
date. Late payments for all payments under this Agreement shall bear interest at a rate of fifteen
percent (15%) effective annual percentage rate of the past due amount.

     4.4 Royalty Reports and Accounting.

          (a) Royalty Reports. Manufacture shall furnish to Fallbrook a monthly written report
showing in reasonably specific detail the calculation of royalties owing for the reporting period,
wherein such detailed information shall include at least that information required to verify the
basis and amount of the royalty including itemized costs and revenues necessary to determine the
proper royalty payment. By way of example, and not limiting the type or amount of information
required hereunder, for royalties owing for the sale of Products, the report shall include at least
the following information: customer name, number of Products shipped, invoice date (along with any
other terms or information that affect the accrual date), price per unit, extended price, nets and
the calculation of the royalties. Furthermore, the royalty report shall include a detailed report
of the shipping activities for the subject month, including customer names, number of units
shipped, customer location, quantity on back order, shipping dates and any other pertinent shipping
information. With respect to sales of Products invoiced in United States dollars, all amounts
shall be expressed in United States dollars. With respect to sales of Products invoiced in a
currency other than United States dollars, all amounts shall be expressed in the domestic currency
of the party making the sale together with the United States dollar equivalent. The United States
dollar equivalent shall be calculated using the average of the exchange rate (local currency per
US$1) published in The Wall Street Journal, Western Edition, under the heading “Currency Trading”
averaged over each month during the applicable

 

			
	***	 	Portions of this page have been omitted
pursuant to a request for Confidential Treatment filed separately with the
Commission.

Proprietary Information

 5 of 20

 

LICENSE AGREEMENT

calendar quarter. Reports shall be due on the twentieth (20th) calendar day following the end
of each calendar month. Manufacturer shall keep complete and accurate records of units of Product
sold in sufficient detail to enable the royalties payable hereunder to be determined.

          (b) Audits. Upon the written request of Fallbrook, Manufacturer shall permit
Fallbrook or its representatives access during normal business hours to such of the records of
Manufacturer as may be reasonably necessary to verify the accuracy of the payment reports
hereunder. If such audit shows that additional amounts were owed during the audited period,
Manufacturer shall pay such additional amounts within thirty (30) days following receipt of notice
of such discrepancy. Fallbrook shall pay for such audit; provided, however, if the audit discloses
that the royalties actually owing by Manufacturer for such period are more than one hundred five
percent (105%) of the royalties actually paid for such period, then Manufacturer shall pay the
reasonable fees and expenses incurred by Fallbrook for such audit.

5. DEVELOPMENT AND COMMERCIALIZATION EFFORTS

     5.1 Development Efforts. In order for Manufacturer to maintain the exclusivity rights
set forth in Section 3.1(a), Manufacturer shall meet each of the following milestones (“Exclusivity
Requirements”).

          (a) Develop and deliver to Fallbrook within three (3) months an acceptable plan, in
Fallbrook’s sole and reasonable discretion, describing in reasonable detail the design and
fabrication steps necessary to deliver the other Exclusivity Requirements, including pre-production
and production intent designs, within the timeframe required for each of the other Exclusivity
Requirements.

          (b) Modify an existing bicycle Transmission design for wind turbine use within twelve (12)
months of the Effective Date.

          (c) Complete a statistically significant amount of field testing of the modified Transmission
with a summary report of the results comparing it to a comparable standard unit within eighteen
(18) months of the Effective Date.

          (d) Design, fabrication and initial performance and quality testing of a wind-specific,
preproduction Transmission including a specification document for the design, a conceptual design,
a detail design including release of part drawings, and prototype fabrication within twenty-eight
(28) months of the Effective date.

          (e) Complete a production intent design and production intent prototype fabrication within
thirty-six (36) months.

          (f) Manufacture a first production unit within forty-two (42) months of the Effective Date.

     5.2 Alternate Milestones. If Manufacturer fails to meet any of the Exclusivity
Requirements provided under Section 5.1, Manufacturer may still maintain exclusivity for so long at
it achieves and maintains any of the following business milestones (each an “Alternative
Milestone”):

Proprietary Information

 6 of 20

 

LICENSE AGREEMENT

          (a) The execution and performance under a bona fide contract with a total value to
Manufacturer of five million US dollars ($5,000,000), with at least one million US dollars
($1,000,000) of that being up front, for the manufacture of, or for a joint venture (of the same
value to Manufacturer) for the manufacture of, a Transmission specifically for wind power
generation.

          (b) Close within nine (9) months of the opening, of a second round of financing for
Manufacturer that results in at least fifteen million US dollars ($15,000,000) in new capital.

          (c) Receipt of, and continuing production work under, a bona fide purchase agreement or
purchase order from a third party for at least one million US dollars ($1,000,000) worth of Product
over a period no longer than twenty four (24) months after the purchase agreement or purchase order
submission date.

          (d) Execution of and performance under a bona fide agreement for the acquisition or
manufacture of Transmissions specifically for the generation of wind power from a government agency
or primary contractor for the benefit of a government agency with a value to Manufacturer of at
least five million US dollars ($5,000,000).

If Manufacturer is able to achieve any of the Alternate Milestones, then the exclusivity granted
under Section 3.1(a) shall continue for so long as the activity in the subject Alternative
Milestone is being undertaken in good faith. If at any point the activity under the Alternative
Milestone is no longer being conducted (whether by termination of the applicable agreement or joint
venture, or by cancellation of the purchase agreement or purchase order), then the exclusivity
under Section 3.1(a) shall not be extended pursuant to this Section 5.2, and shall only remain in
effect if all of the Exclusivity Requirements under Section 5.1 have been satisfied in accordance
with their associated timeline.

     5.3 Failure of Development Efforts. If Manufacturer fails to satisfy any of the
Exclusivity Requirements under Section 5.1, subject to the opportunity to extend exclusivity by
achieving and maintaining an Alternative Milestone under Section 5.2, then upon written notice from
Fallbrook to Manufacturer, Manufacturer shall have a period of thirty (30) days following such
notice to provide Fallbrook with a plan for curing such failures that is acceptable to Fallbrook in
its sole good faith discretion. If Manufacturer is unable to provide such an acceptable plan to
Fallbrook during such thirty (30) day period, then upon the expiration of such thirty (30) day
period the license grants to Manufacturer under Section 3.1(a) shall become non-exclusive. If
Manufacturer is able to provide an acceptable plan to Fallbrook, but subsequently fails to
materially satisfy the obligations set forth in such plan, then Fallbrook shall have the right to
terminate the exclusivity under Section 3.1(a) of this Agreement by written notice to Manufacturer.

     5.4 Records. Manufacturer shall maintain records, in sufficient detail and in good
scientific manner, which shall reflect all work done and results achieved in the performance of its
research and development regarding the Licensed IP Rights, Improvements and the Products (including
all data in the form required under all applicable laws and regulations). Fallbrook shall have the
right to access and review such records upon reasonable written notice.

Proprietary Information

 7 of 20

 

LICENSE AGREEMENT

     5.5 Reports.

          (a) Within thirty (30) days following the end of each calendar quarter during the term of this
Agreement, Manufacturer shall prepare and deliver to Fallbrook a written report describing in
detail any Improvements made or conceived during such calendar quarter.

          (b) Within ninety (90) days following the end of each calendar year during the term of this
Agreement, Manufacturer shall prepare and deliver to Fallbrook a written summary report which shall
describe the research, development and commercialization of Products during such year.

          5.6 Quality. In order to maintain the quality of the Products manufactured by
Manufacturer under this Agreement, to develop a method of continuously reducing the cost of
producing Products, and to protect the value of the Licensed Marks, Manufacture shall establish a
quality management system (QMS) and quality operating standards (QOS) that govern each process in
the manufacture of Products to add value in the overall manufacturing process, to obtain results of
process performance and effectiveness and to achieve continual improvement of each process based
upon an objective measurement. At a minimum, the QOS shall include at least all of the following:
(i) a continuous improvement plan aimed at the elimination of manufacturing defects,
(ii) documentation of all process and procedures, including root cause analysis, corrective action
development and tracking plans, recovery and communication plan, and a statistical measurement
process. The documentation of the documented QOS processes and procedures, and any reports
generated by these shall be made available to Fallbrook upon request for auditing purposes for
compliance with requirements hereunder, which audits shall occur on no more frequent basis than
quarterly.

          (a) Inspections. At its discretion, Fallbrook shall have access to Products
manufactured by or on behalf of Manufacturer under this Agreement, either at any manufacturing
facilities or at Fallbrook’s own facilities, in Fallbrook’s sole and reasonable discretion, to
ensure Products are manufactured with reasonable quality for the Field of Use.

          (b) Reports. Fallbrook may at is discretion submit quality reports indicating
insufficiencies in the manufacturing process or quality to Manufacturer. If such a quality report
is submitted to Manufacturer, then Manufacturer must correct the stated insufficiencies or submit
to Fallbrook a plan for correcting the insufficiencies suitable to Fallbrook within thirty (30)
days. Failure to submit a timely response suitable to Fallbrook in its sole and reasonable
discretion shall be considered a material breach.

6. HONORABLE BEHAVIOR

     6.1 Conduct. Fallbrook and Manufacturer shall act honorably towards each other and
towards all other NuVinci Licensees (as defined below).

     6.2 Covenant Not To Sue. Manufacturer will not assert any claims or rights, by
commencing, or causing to be commenced, any action or proceeding that alleges infringement by any
NuVinci Licensee under the Manufacturer IP Rights (as defined below) based in whole or in part on
the use, making, having made, offering for sale, selling, or importing NuVinci Products (as defined
below). In addition, Manufacturer grants to each NuVinci Licensee under the

Proprietary Information

 8 of 20

 

LICENSE AGREEMENT

Manufacturer IP Rights immunity from suit for infringement based in whole or in part on the on
the use, making, having made, offering for sale, selling or importing NuVinci Products. This
covenant will be binding on all successors in interest to, all transferees or assignees of and any
exclusive licensee of any Manufacturer IP Rights. Any NuVinci Licensee that has agreed with
Fallbrook to the same or a similar covenant will be regarded as an intended third party beneficiary
of this covenant with the right to enforce this covenant.

     6.3 Definitions. As used in this Section 6, (a) “NuVinci Licensee” shall mean
any manufacturer, OEM or other entity, in each case that has agreed to a covenant the same as or
substantially similar to the terms of the covenant set forth above, and each of their customers,
(b) “Manufacturer IP Rights” shall mean any patents or other intellectual property rights,
other than trademarks or trade dress, owned or controlled by Manufacturer prior to or during the
term of this Agreement which are useful to use, make, have made, offer for sale, sell or import
NuVinci Products, and (c) “NuVinci Products” shall mean any product that uses or
incorporates the NuVinci continuously variable transmission technology and that uses, incorporates
or is read upon by any Fallbrook intellectual property (including without limitation patents and
know-how).

7. CONFIDENTIALITY

     7.1 Confidential Information. During the term of this Agreement and following the
expiration or earlier termination of this Agreement, Manufacturer shall maintain in confidence all
Confidential Information disclosed by Fallbrook, and shall not use, disclose or grant the use of
such Confidential Information without express written permission of Fallbrook except on a
need-to-know basis to those directors, officers, employees, consultants, contractors or permitted
assignees, to the extent such disclosure is reasonably necessary in connection with Manufacturer’s
activities as expressly authorized by this Agreement. To the extent that disclosure is authorized
by this Agreement, prior to disclosure, Manufacturer shall obtain agreement of any such person or
entity to hold in confidence and not make use of the Confidential Information for any purpose other
than those permitted by this Agreement. Manufacturer shall notify Fallbrook promptly upon
discovery of any unauthorized use or disclosure of the Confidential Information.

     7.2 Permitted Disclosures. The confidentiality obligations contained in this
Section 6 shall not apply to the extent that Manufacturer is required to disclose information by
law, order or regulation of a governmental agency or a court of competent jurisdiction, provided
that the Manufacturer shall provide written notice thereof to Fallbrook and sufficient opportunity
to object to any such disclosure or to request confidential treatment thereof.

8. INTELLECTUAL PROPERTY

     8.1 Assignment of Improvements. All right, title and interest in the Improvements to
Transmissions, together with all patent rights and other intellectual property rights therein,
shall be owned by Fallbrook, but such Improvements shall become part of the Licensed IP Rights
hereunder and shall thereby be available to Manufacturer. Manufacturer hereby assigns and
transfers to Fallbrook all of Manufacturer’s right, title and interest therein and thereto.
Manufacturer shall cause all employees and other persons or entities acting on its behalf in

Proprietary Information

 9 of 20

 

LICENSE AGREEMENT

performing any research and development conducted pursuant to the rights granted under this
Agreement to be obligated under a binding written agreement to assign to it, or as it shall direct,
all Improvements made or conceived by such employees or other persons or entities. Manufacturer
shall perform, during and after the term of this Agreement, all acts that Fallbrook deems necessary
or desirable to permit and assist Fallbrook, at Fallbrook’s expense, in obtaining, perfecting and
enforcing the full benefits, enjoyment, rights and title throughout the world in the Improvements
as provided in this Agreement. If Fallbrook is unable for any reason to secure Manufacturer’s
signature to any document required to file, prosecute, register or memorialize the assignment of
any rights as provided under this Agreement, Manufacturer hereby irrevocably designates and
appoints Fallbrook and Fallbrook’s duly authorized officers and agents as Manufacturer’s agents and
attorneys-in-fact to act for and on Manufacturer’s behalf and instead of Manufacturer to take all
lawfully permitted acts to further the filing, prosecution, registration, memorialization of
assignment, issuance and enforcement of such rights, all with the same legal force and effect as if
executed by Manufacturer. The foregoing is deemed a power coupled with an interest and is
irrevocable.

     8.2 Patents.

          (a) Fallbrook shall have the right (but not the obligation) at its sole expense and in its
sole discretion to control the preparation, filing, prosecution, maintenance and enforcement of the
Licensed Patents. Manufacturer shall notify Fallbrook of any infringement in the Territory known
to Manufacturer of the Licensed Patents and shall provide Fallbrook with the available evidence, if
any, of such infringement.

          (b) Manufacturer shall mark each Product with the appropriate notices of issued patents and
pending patent applications covering such Product as necessary under applicable law or regulation
in order for Fallbrook to fully exploit its applicable patent rights.

     8.3 Trademark.

          (a) All right, title, and interest in and to the Licensed Mark, other than Manufacturer’s
right to use as described in Section 3.1(b), above, shall remain with Fallbrook. During the term
of this Agreement and thereafter, Manufacturer will not contest Fallbrook’s exclusive right, title
and interest in and to, or the validity of, the Licensed Mark. In addition, Manufacturer will not
in any manner represent that it has any interest in the Licensed Mark, except for the limited
license provided herein. Use of the Licensed Mark by Manufacturer shall not confer upon
Manufacturer any right, title or interest in or to the Licensed Mark, and all such use by
Manufacturer of the Licensed Mark, including any goodwill generated therefrom, shall inure to the
sole benefit of and be on behalf of Fallbrook.

          (b) Manufacturer shall incorporate the Licensed Mark on each Product. Manufacturer agrees
that use by Manufacturer of the Licensed Mark, as provided herein, shall be in accordance with all
applicable law and regulations, shall conform with all style and other guidelines provided by
Fallbrook from time to time, shall be of high quality and standards and shall not adversely affect
the good name of Fallbrook.

Proprietary Information

 10 of 20

 

LICENSE AGREEMENT

          (c) Manufacturer will not use any marks or names similar to Fallbrook, as Fallbrook may
determine. Manufacturer agrees (i) not to use any other trademark, service mark or trade name on
the materials or in close proximity to any Licensed Mark and (ii) not to combine the marks so as to
possibly create a unitary composite mark, as Fallbrook may determine in its discretion.

          (d) Manufacturer agrees to notify Fallbrook of any unauthorized use of the Licensed Mark by
others promptly as it comes to Manufacturer’s attention. Fallbrook shall have the sole right and
discretion to bring infringement or unfair competition proceedings involving the Licensed Mark.

          (e) Fallbrook shall have the right, but not the obligation, to file in the appropriate
offices, at its own expense, trademark or design applications relating to the Licensed Marks, such
filings to be made in the name of Fallbrook or in the name of any third party selected by
Fallbrook. To assist Fallbrook with its registration of the Licensed Mark in the name of
Fallbrook, Manufacturer, at Fallbrook’s request and expense, shall promptly perform any act
necessary for Fallbrook to secure or maintain any and all Fallbrook trademark rights. Manufacturer
agrees not to register any Licensed Mark in Manufacturer’s name or any confusingly similar
trademark in any country, in any character form, as Fallbrook may determine in its discretion.

          (f) With respect to each Product that Manufacturer proposes to offer for sale or sell under
this Agreement, and each marketing, promotional or sales literature relating to the Product that
Manufacturer intends to use (including without limitation any materials that use or incorporate the
Licensed Mark), Manufacturer shall first submit to Fallbrook a sample of such Product or literature
for Fallbrook’s prior review and written approval or disapproval, which review shall be based upon
those standards for all Products and Licensed Marks that are attached as Exhibit C hereto (as
amended from time to time by Fallbrook). Fallbrook agrees to use reasonable efforts to notify
Manufacturer in writing of its approval or disapproval of any Product or literature submitted to it
under this Section 8.3(f) within thirty (30) business days after receipt. Manufacturer shall not
have the right to offer for sale or sale any Product, or use or distribute any such literature, in
each case which has not been approved by Fallbrook as provided herein. Notwithstanding the
foregoing, Manufacturer will comply with all reasonable procedures which Fallbrook may from time to
time adopt regarding performance criteria of the Products and the display of registration notices,
legends, or symbols in connection with the Licensed Mark.

9. TERMINATION

     9.1 Expiration. Unless earlier terminated pursuant to Sections 5.3, 9.2 or 9.3, the
term of this Agreement shall commence on the Effective Date and shall continue for seven (7) years.

     9.2 Termination by Manufacturer. Manufacturer may terminate this Agreement, in its
sole discretion, upon thirty (30) days prior written notice to Fallbrook.

Proprietary Information

 11 of 20

 

LICENSE AGREEMENT

     9.3 Termination for Cause. Fallbrook may terminate this Agreement upon or after the
material breach of this Agreement by Manufacturer if Manufacturer has not cured such material
breach within thirty (30) days after written notice thereof by Fallbrook.

     9.4 Effect of Expiration or Termination. Expiration or termination of this Agreement
shall not relieve the parties of any obligation accruing prior to such expiration or termination,
and the provisions of Sections 5.4, 5.5, 6, 7, 8, 9.4, 10 and 11 shall survive the expiration or
termination of this Agreement.

10. INDEMNIFICATION

     10.1 Indemnification. Manufacturer shall defend, indemnify and hold the Fallbrook
harmless from all losses, liabilities, damages and expenses (including reasonable attorneys’ fees
and costs) resulting from any claims, demands, actions and other proceedings by any Third Party to
the extent resulting from Manufacturer’s use, of the Licensed IP Rights or Licensed Mark, or the
import or export of technology or products under this Agreement.

     10.2 Procedure. Fallbrook promptly shall notify Manufacturer of any claim, demand,
action or other proceeding for which Fallbrook intends to claim indemnification. Manufacturer
shall have the right to participate in, and to the extent Manufacturer so desires jointly with any
other indemnitor similarly noticed, to assume the defense thereof with counsel selected by
Manufacturer; provided, however, that Fallbrook shall have the right to retain its own counsel,
with the fees and expenses to be paid by Manufacturer, if representation of Fallbrook by the
counsel retained by Manufacturer would be inappropriate due to actual or potential differing
interests between Fallbrook and any other party represented by such counsel in such proceedings.
Manufacturer may not settle or otherwise consent to an adverse judgment in any such claim, demand,
action or other proceeding, that diminishes the rights or interests of Fallbrook without the prior
express written consent of Fallbrook.

     10.3 Insurance. Manufacturer shall, within ninety (90) days of the Effective Date,
maintain insurance in an amount that is at least one million ($1,000,000.00) US dollars with
respect to the research, development and commercialization of Products by Manufacturer or, if
greater, in such amount as Manufacturer customarily maintains with respect to the research,
development and commercialization of its similar products. Manufacturer shall maintain such
insurance for so long as it continues to research, develop or commercialize any Products, and
thereafter for so long as Manufacturer customarily maintains insurance covering the research,
development or commercialization of its similar products.

11. MISCELLANEOUS

     11.1 Notices. Any consent, notice or report required or permitted to be given or made
under this Agreement by one of the parties to the other shall be in writing and addressed to such
other party at its address indicated below, or to such other address as the addressee shall have
last furnished in writing to the addressor, and shall be effective upon receipt by the addressee.

Proprietary Information

 12 of 20

 

LICENSE AGREEMENT

	 	 	 	 	 
	     If to Fallbrook:

	 	Fallbrook Technologies Inc.	 	 
	 

	 	9444 Waples St., Suite 410	 	 
	 

	 	San Diego, California 92121	 	 
	 

	 	Attention: Vice President, Intellectual Property	 	 
	 
	 	 	 	 
	With a copy to:
	 	 	 	 
	 

	 	Morrison Foerster LLP	 	 
	 

	 	12531 High Bluff Drive	 	 
	 

	 	San Diego, CA 92130	 	 
	 

	 	Attention: Jake Handy	 	 
	 
	 	 	 	 
	     If to Manufacturer:

	 	Viryd Technologies Inc.	 	 
	 

	 	 
 

	 	 
	 

	 	 
 

	 	 
	 

	 	 
 

	 	 

     11.2 Assignment. Neither this Agreement nor any right or obligation hereunder may be
assigned or otherwise transferred (whether voluntarily, by operation of law, in connection with a
change in control or otherwise) by Manufacturer, without the prior express written consent of
Fallbrook. Upon request for transfer or assignment of any right or duty hereunder by Manufacturer,
Fallbrook shall be entitled to request, and Manufacturer shall deliver, whatever corporate
documents Fallbrook may desire in order to determine the existing and proposed ownership structure.
Any permitted assignee shall assume all obligations of Manufacturer under this Agreement. Any
purported assignment or transfer in violation of this Section 11.2 shall be void.

     11.3 Applicable Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of California, without regard to the conflicts of law principles
thereof.

     11.4 Entire Agreement. This Agreement contains the entire understanding of the
parties with respect to the subject matter hereof. All express or implied representations,
agreements and understandings, either oral or written, heretofore made are expressly superseded by
this Agreement.

     11.5 Independent Contractors. Each party hereby acknowledges that the parties shall
be independent contractors and that the relationship between the parties shall not constitute a
partnership, joint venture or agency. Neither party shall have the authority to make any
statements, representations or commitments of any kind, or to take any action, which shall be
binding on the other party, without the prior consent of the other party to do so.

     11.6 Waiver. The waiver by a party of any right hereunder, or of any failure to
perform or breach by the other party hereunder, shall not be deemed a waiver of any other right
hereunder or of any other breach or failure by the other party hereunder whether of a similar
nature or otherwise.

Proprietary Information

 13 of 20

 

LICENSE AGREEMENT

     11.7 Force Majeure.Neither party shall be held liable or responsible to the other
party nor be deemed to have defaulted under or breached this Agreement for failure or delay in
fulfilling or performing any term of this Agreement to the extent, and for so long as, such failure
or delay is caused by or results from causes beyond the reasonable control of the affected party
including but not limited to fire, floods, embargoes, war, acts of war (whether war be declared or
not), insurrections, riots, civil commotions, strikes, lockouts or other labor disturbances, acts
of God or acts, omissions or delays in acting by any governmental authority or the other party.

     11.8 Counterparts. This Agreement may be executed in two or more counterparts, each
of which shall be deemed an original, but all of which together shall constitute one and the same
instrument.

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the Effective Date.

	 	 	 	 	 
	 	FALLBROOK TECHNOLOGIES INC.

 	 
	 	By  	/s/ William Klehm
 	 
	 	Title CEO 	 
	 	 	 	 
	 
	 	VIRYD TECHNOLOGIES INC.

 	 
	 	By  	/s/ Nicole Nicks
 	 
	 	Title  CFO 	 
	 	 	 	 
	 

Proprietary Information

 14 of 20

 

LICENSE AGREEMENT

EXHIBIT A

Licensed Patents

	 	 	 	 	 	 	 	 	 	 	 
	Country:	 	Application No.	 	Filing Date:	 	Patent No:	 	Date Issued:
	US

	 	09/133284
	 	8/12/1998
	 	 	6241636	 	 	6/5/2001
	US

	 	09/823620
	 	3/30/2001
	 	 	6322475	 	 	11/27/2001
	US

	 	09/695757
	 	10/24/2000
	 	 	6419608	 	 	7/16/2002
	US

	 	10/141652
	 	5/7/2002
	 	 	6551210	 	 	4/22/2003
	US

	 	10/903617
	 	7/29/2004
	 	 	7032914	 	 	4/25/2006
	US

	 	10/134097
	 	4/25/2002
	 	 	6689012	 	 	2/10/2004
	US

	 	10/770966
	 	2/3/2004
	 	 	6949049	 	 	9/27/2005
	US

	 	11/006341
	 	12/6/2004
	 	 	7175566	 	 	2/13/2007
	US

	 	11/006026
	 	12/6/2004
	 	 	7147586	 	 	12/12/2006
	US

	 	11/006315
	 	12/6/2004
	 	 	7175565	 	 	2/13/2007
	US

	 	11/005915
	 	12/6/2004
	 	 	7172529	 	 	2/6/2007
	US

	 	11/005916
	 	12/6/2004
	 	 	7112159	 	 	9/26/2006
	US

	 	11/006115
	 	12/6/2004
	 	 	7131930	 	 	11/7/2006
	US

	 	11/006448
	 	12/6/2004
	 	 	7192381	 	 	3/20/2007
	US

	 	11/006021
	 	12/6/2004
	 	 	7166057	 	 	1/23/2007
	US

	 	11/006355
	 	12/6/2004
	 	 	7166058	 	 	1/23/2007
	US

	 	11/007531
	 	12/7/2004
	 	 	7153233	 	 	12/26/2006
	US

	 	10/788736
	 	2/26/2004
	 	 	7011600	 	 	3/14/2006
	US

	 	11/030372
	 	1/5/2005
	 	 	7238136	 	 	7/3/2007
	US

	 	11/030415
	 	1/5/2005
	 	 	7238137	 	 	7/3/2007
	US

	 	11/030361
	 	1/5/2005
	 	 	7036620	 	 	5/2/2006
	US

	 	11/030624
	 	1/5/2005
	 	 	7238138	 	 	7/3/2007
	US

	 	11/030209
	 	1/5/2005
	 	 	7232395	 	 	6/19/2007
	US

	 	11/030625
	 	1/5/2005
	 	 	7125297	 	 	10/24/2006
	US

	 	11/030018
	 	1/5/2005
	 	 	7198585	 	 	4/3/2007
	US

	 	11/030210
	 	1/5/2005
	 	 	7166056	 	 	1/23/2007
	US

	 	11/030535
	 	1/5/2005
	 	 	7169076	 	 	1/30/2007
	US

	 	10/844821
	 	5/12/2004
	 	 	7166052	 	 	1/23/2007
	US

	 	11/051364
	 	2/3/2005
	 	 	7214159	 	 	5/8/2007
	US

	 	11/051115
	 	2/3/2005
	 	 	7201695	 	 	4/10/2007
	US

	 	11/051052
	 	2/3/2005
	 	 	7204777	 	 	4/17/2007
	US

	 	11/051611
	 	2/3/2005
	 	 	7198584	 	 	4/3/2007
	US

	 	11/051093
	 	2/3/2005
	 	 	7198583	 	 	4/3/2007
	US

	 	11/051063
	 	2/3/2005
	 	 	7201694	 	 	4/10/2007
	US

	 	10/418509
	 	4/16/2003
	 	 	6945903	 	 	9/20/2005
	US

	 	11/006114
	 	12/6/2004
	 	 	7063640	 	 	6/20/2006
	US

	 	11/006216
	 	12/6/2004
	 	 	7044884	 	 	5/16/2006
	US

	 	11/005673
	 	12/6/2004
	 	 	7014591	 	 	3/21/2006

Proprietary Information

 15 of 20

 

LICENSE AGREEMENT

	 	 	 	 	 	 	 	 	 
	Country:	 	Application No.	 	Filing Date:	 	Patent No:	 	Date Issued:
	US
	 	11/006213
	 	12/6/2004
	 	7074154
	 	7/11/2006
	BE
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003
	CA
	 	2306557
	 	10/22/1998
	 	2306557
	 	12/12/2006
	CH
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003
	CN
	 	98812170
	 	10/22/1998
	 	ZL98812170.0
	 	4/21/2004
	CN
	 	00818383.X
	 	10/24/2000
	 	ZL 00818383.X
	 	11/16/2005
	DE
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003
	DK
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003
	EP
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003
	ES
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003
	FI
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003
	FI
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003
	FR
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003
	GB
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003
	HK
	 	3109065.8
	 	10/24/2000
	 	HK1056764
	 	5/26/2006
	IE
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003
	RU
	 	2003129641
	 	4/25/2002
	 	2289045
	 	12/10/2006
	SE
	 	988508.8
	 	10/24/2000
	 	1235997
	 	12/17/2003

Licensed Patent Applications

	 	 	 	 	 
	Country:	 	Application No.	 	Filing Date:
	US

	 	11/330425
	 	1/11/2006
	US

	 	11/688124
	 	3/19/2007
	US

	 	11/030442
	 	1/5/2005
	US

	 	11/030211
	 	1/5/2005
	US

	 	11/030627
	 	1/5/2005
	US

	 	11/176545
	 	7/7/2005
	US

	 	10/949741
	 	9/24/2004
	US

	 	11/243484
	 	10/4/2005
	US

	 	11/509789
	 	8/23/2006
	US

	 	11/585677
	 	10/24/2006
	US

	 	11/562317
	 	11/21/2006
	US

	 	11/543311
	 	10/3/2006
	US

	 	60/864941
	 	11/8/2006
	US

	 	60/889512
	 	2/12/2007
	US

	 	60/890438
	 	2/16/2007
	US

	 	60/913771
	 	4/24/2007
	US

	 	60/915872
	 	5/3/2007
	US

	 	60/943273
	 	6/11/2007
	US

	 	60/948152
	 	7/5/2007
	US

	 	11/694145
	 	3/30/2007

Proprietary Information

 16 of 20

 

LICENSE AGREEMENT

	 	 	 	 	 
	US
	 	11/694492	 	3/30/2007
	US
	 	11/694049	 	3/30/2007
	US
	 	11/694044	 	3/30/2007
	US
	 	11/694016	 	3/30/2007
	US
	 	11/694066	 	3/30/2007
	US
	 	11/693998	 	3/30/2007
	US
	 	11/694107	 	3/30/2007
	US
	 	11/694119	 	3/30/2007
	AU
	 	2002303524	 	4/25/2002
	AU
	 	2004217514	 	2/27/2004
	AU
	 	2005269791	 	7/19/2005
	AU
	 	2005294611	 	10/3/2005
	AU
	 	2004212584	 	10/24/2000
	BR
	 	PI0407856-0	 	2/27/2004
	CA
	 	2559944	 	10/22/1998
	CA
	 	2388988	 	10/24/2000
	CA
	 	2443808	 	4/25/2002
	CA
	 	2516494	 	2/27/2004
	CA
	 	2582562	 	10/3/2005
	CN
	 	200510074338.2	 	10/24/2000
	CN
	 	2809761	 	4/25/2002
	CN
	 	200480011347	 	2/27/2004
	CN
	 	200580038511.1	 	10/3/2005
	CN
	 	200610100176.X	 	10/24/2000
	CN
	 	200610100175.5	 	10/24/2000
	CN
	 	200610100194.8	 	10/24/2000
	CN
	 	200610100193.3	 	10/24/2000
	CN
	 	200610100180.6	 	10/24/2000
	EP
	 	98953912.7	 	10/22/1998
	EP
	 	2731549.8	 	4/25/2002
	EP
	 	4715691.4	 	2/27/2004
	EP
	 	5800165.2	 	10/3/2005
	EP
	 	5028709.3	 	12/30/2005
	HK
	 	6107559.2	 	10/24/2000
	HK
	 	5104944.4	 	4/25/2002
	HK
	 	6105840.5	 	2/27/2004
	IN
	 	1755/KNOLP/2005	 	2/27/2004
	IN
	 	1225/KOLNP/2007	 	10/3/2005
	JP
	 	2000-517205	 	10/22/1998
	JP
	 	2002-585835	 	4/25/2002
	JP
	 	2006-508892	 	2/27/2004
	KR
	 	10-2003-7014061	 	4/25/2002
	KR
	 	10-2005-7016056	 	2/27/2004
	KR
	 	10-2007-7010267	 	10/3/2005
	MX
	 	PA/a/2003/009830	 	4/25/2002

Proprietary Information

 17 of 20

 

LICENSE AGREEMENT

	 	 	 	 	 
	MX
	 	MX/a/2007/004449	 	4/25/2002
	MX
	 	MX/a/2007/004453	 	4/25/2002
	MX
	 	MX/a/2007/004452	 	4/25/2002
	MX
	 	MX/a/2007/00448	 	4/25/2002
	MX
	 	MX/a/2007/004451	 	4/25/2002
	MX
	 	PA/a/2005/009106	 	2/27/2004
	MX
	 	MX/a/2007/003828	 	10/3/2005
	TW
	 	94134761	 	10/5/2005
	TW
	 	95131108	 	8/24/2006
	TW
	 	95139495	 	10/26/2006
	TW
	 	95142962	 	11/21/2006
	TW
	 	95143152	 	11/22/2006
	TW
	 	95137289	 	10/11/2006
	TW
	 	96122902	 	6/25/2007

Proprietary Information

 18 of 20

 

LICENSE AGREEMENT

EXHIBIT B

Licensed Mark

NuVinci

(word mark or stylized)

	 	 	 
	

	 	

Proprietary Information

 19 of 20

 

LICENSE AGREEMENT

EXHIBIT C

Standards

Graphics Standards:

	 	ð	 	The Licensed Mark must be used in accordance with Fallbrook’s Graphic Standard as
it may be amended from time to time

NuVinci® Technology Name Usage

	 	ð	 	In all copy, transcripts, and content, NuVinci® Technology must be spelled out with
a capital letter “V”, must include a ® symbol after NuVinci in at least its first or most
conspicuous usage, should be distinguished from the rest of the text it is used with
preferably by use of an italicized font, and must always be followed by words such as:
Technology, Compound Variable Planetary, Continuously Variable Planetary drive, CVP, CVP
drive, CVP transmission, transmission, Brand or other suitable noun.
	 
	 	ð	 	Correct usage: NuVinci® technology...NuVinci CVP... NuVinci brand
	 
	 	ð	 	Incorrect usage: Nuvinci...NuVinci TM ...it’s a NuVinci and... .

Company and NuVinci® Technology Signature Logo Guidelines

	 	ð	 	Corporate and NuVinci Technology signature logos must be used directly from a stat
sheet or an official digital logo file obtained directly from Fallbrook Technologies Inc.
Logos may not be made from “scrap” or from printed collateral material, and must not be
recreated or regenerated.
	 
	 	ð	 	The Fallbrook Technologies and NuVinci Technology signature logos must be used as
presented. They can never be hand drawn in illustrations. Logos must be properly stripped
into place in all ads, collateral and electronic materials.
	 
	 	ð	 	There can be no distortion of logos in any design element at any time. All
illustrations must be prepared to be consistent with the appearance and tone of the logos
or variations authorized herein.
	 
	 	ð	 	All Fallbrook Technologies trademarks are either trademarks or registered trademarks and
any unauthorized use, including use that is not in accordance with these guidelines is
prohibited.
	 
	 	ð	 	All reproduction of Fallbrook Technologies and/or NuVinci Technology logos must be
pre-approved by Fallbrook Technologies Inc. prior to publication. Reasonable business
efforts shall be made to expedite the approval process.

Corporate and NuVinci Technology Logo Color Guide

	 	ð	 	Two-color: PMS Black + PMS179 sphere.
	 
	 	ð	 	Three-color: PMS Black + PMS 179 sphere + PMS 134 sphere highlight.
	 
	 	ð	 	Logos may be reproduced as one-color in PMS Black against a white or light field of
color; or reversed out as a single white image out of a black or solid color field.

Dos & Don’ts Guidelines

	 	ð	 	Do provide attribution to Fallbrook Technologies Inc. as the owner of the
trademarks when you utilize them.
	 
	 	ð	 	Do use the full company name: Fallbrook Technologies Inc. or the trademark Fallbrook
Technologies.
	 
	 	ð	 	Do use NuVinci Technology trademark properly: NuVinciTM CVP (first usage) or
NuVinci CVP (subsequent usage).
	 
	 	ð	 	Do use only the approved colors for 2 and 3 color logos.
	 
	 	ð	 	Do provide an area of isolation of white space immediately around the logos equal to a
minimum of half the height of the logo above, below and beside the mark.
	 
	 	ð	 	Don’t alter logo artwork and electronic files.
	 
	 	ð	 	Don’t place logo in any containment shape.
	 
	 	ð	 	Don’t use the logos without trademark attribution and marking.
	 
	 	ð	 	Don’t reproduce without artwork approval by Fallbrook Technologies Inc.

Proprietary Information

 20 of 20exv10w8

EXHIBIT 10.8

MASTER AGREEMENT

     This MASTER AGREEMENT (this “Agreement”) is made as of November 25, 2008 (the “Effective
Date”), by and between VIRYD TECHNOLOGIES INC., a Delaware corporation with a place of business at
9444 Waples Street, Suite 410, San Diego, California 92121 (“Viryd”), and FALLBROOK TECHNOLOGIES
INC., a Delaware corporation with a place of business at 9444 Waples Street, Suite 410, San Diego,
California 92121 (“Fallbrook”).

     WHEREAS, Viryd and Fallbrook entered into that certain License Agreement dated February 14,
2008 (the “License Agreement”) pursuant to which Fallbrook granted to Viryd certain exclusive
rights in the wind turbine field;

     WHEREAS, Viryd and Fallbrook entered into that certain Patent Assignment Agreement dated
February 20, 2007 (the “Assignment Agreement”) pursuant to which Fallbrook sold and assigned to
Viryd certain patents covering inventions in the wind turbine field;

     WHEREAS, Viryd and Fallbrook entered into that certain Engineering Services Agreement dated
April 28, 2008, and as amended by Amendment No. 1 dated June 10, 2008 (the “Engineering Agreement”)
pursuant to which Fallbrook provides certain engineering services to Viryd with respect to the
development of continuously variable transmissions based on Fallbrook’s NuVinciTM technology for use
in the wind turbine field;

     WHEREAS, Viryd and Fallbrook entered into that certain Support Services Agreement dated
February 15, 2008, and as amended by Amendment No. 1 dated March 3, 2008 (the “Support Agreement”)
pursuant to which Fallbrook provides certain engineering and administrative support services to
Viryd with respect to the development of continuously variable transmissions based on Fallbrook’s
NuVinciTM technology for use in the wind turbine field; and

     WHEREAS, Viryd and Fallbrook now desire to amend the License Agreement, Assignment Agreement
and Engineering Agreement, and to provide for various matters regarding Fallbrook’s assistance to
Viryd and the recapitalization of Viryd’s shares of common stock owned by Fallbrook, all on the
terms and conditions of this Agreement.

     NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein
contained, and for other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereto agree as follows:

1. Fallbrook Assistance.

     1.1 Raising Funds. Upon Viryd’s written request, Fallbrook shall assist Viryd with
its fund raising efforts as follows:

          (a) Fallbrook shall use commercially reasonable efforts to introduce Viryd management and
board members to Fallbrook’s contacts with respect to financing and fund raising;

 

 

          (b) Fallbrook shall provide assistance and guidance to Viryd in the preparation of offering
memoranda and investor presentations;

          (c) Fallbrook shall provide Viryd with assistance and advice in strategic development and
tactics for raising capital; and

          (d) Fallbrook shall provide Viryd with assistance and guidance on negotiating legal documents
related to raising capital; provided, however, that Fallbrook would not be obligated to prepare or
review and approve any such documents.

     1.2 William Klehm. Provided that William Klehm continues to be an employee of
Fallbrook, Fallbrook shall ensure that William Klehm continues to provide support under the Support
Agreement in a manner substantially similar to the manner William Klehm has worked with Viryd under
the Support Agreement prior to the Effective Date. If either Fallbrook or Viryd terminates the
Support Agreement then, at no expense to Viryd, continuing until the earlier of (a) six (6) months
after the Effective Date, or (b) two (2) months after Viryd hires a seasoned chief executive
officer, William Klehm shall continue to work with Viryd in a manner substantially similar to the
manner William Klehm has worked with Viryd under the Support Agreement prior to the Effective Date.
Fallbrook shall additionally make William Klehm available to serve as a board member for Viryd for
at least two (2) years after the Effective Date.

     1.3 Legal Fees. Fallbrook shall directly pay for, or shall reimburse Viryd for, all
legal fees incurred by Viryd in the negotiation and preparation of this Agreement, including the
recapitalization and issuance of Viryd stock as more fully described in Section 0 of this
Agreement.

     1.4 Supply of CVP. In the event Viryd desires to purchase from Fallbrook continuously
variable transmissions based on Fallbrook’s NuVinciTM technology, then the parties shall negotiate
in good faith the supply terms and transfer price for such transmission, provided that the transfer
price shall not exceed (a) one hundred and ten percent (110%) of Fallbrook’s fully burdened costs
to manufacture the transmission, plus (b) the estimated royalty amount that Fallbrook would have
otherwise received on the sale of such transmission by Viryd or its affiliate or sublicensee.

2. Amendments to License Agreement.

     2.1 Section 1. Section 1 of the License Agreement is hereby amended to add the
following new Sections 1.16 and 1.17 immediately after the end of Section 1.15:

     1.16 “Drivetrain Product” shall mean a Product that consists of a Transmission
and the associated drivetrain.

     1.17 “System Product” shall mean a Product that consists of a Transmission, the
associated drivetrain, the enclosed structure (including tower and foundation) and turbine
blades.

     2.2 Section 1.9. Section 1.9 of the License Agreement is hereby amended and restated
in its entirety as follows:

2

 

     1.9 “Sales Price” shall mean with respect to any Transmission Product or
Drivetrain Product (a) where such Transmission Product or Drivetrain Product, as applicable,
is separately itemized or invoiced, the price Manufacturer or its Affiliate or sublicensee
charges its customer for such Transmission Product or Drivetrain Product, as applicable, or
(b) where not separately itemized or invoiced, the sum of (i) the fully burdened cost to
manufacture such Transmission Product or Drivetrain Product, as applicable, and (ii) an
amount equal to the average profit margin Manufacturer or its Affiliate or sublicensee
realizes with its products and services (but in no case less than an amount equal to *** of
the fully burdened cost to manufacture such Transmission Product or Drivetrain Product, as
applicable).

     2.3 Section 1.11. Section 1.11 of the License Agreement is hereby amended and
restated in its entirety as follows:

     1.11 “System Sales Price” shall mean the Sales Price of the System Product.
Notwithstanding the foregoing, System Sales Price shall exclude the cost of labor to
assemble and install the System Product, other than the cost to assemble the Transmission
Product therein, and shall exclude the cost of land and the cost of permits for the System
Product.

     2.4 Section 3.1(a). Section 3.1(a) of the License Agreement is hereby amended by
replacing the parenthetical in the first sentence with “...(with the right to grant sublicenses
through multiple tiers)...” and adding the following sentence to the end of Section 3.1(a):

     Manufacturer shall have the right to grant sublicenses provided that Manufacturer shall
be responsible for paying to Fallbrook a royalty on such sublicensees Sales Price, System
Sales Price and leases as provided in Section 4.2. Manufacturer shall ensure that each such
sublicensee has agreed in writing to be bound to the obligations in Sections 6, 8 and 10 of
this Agreement.

     2.5 Section 4.2. Section 4.2 of the License Agreement is hereby amended and restated
in its entirety as follows:

     4.2 Royalty Rate. Manufacturer shall pay royalties to Fallbrook in accordance
with the following:

     (a) with respect to the sale of Products, Manufacturer shall pay to Fallbrook a royalty
equal to the greater of (i) *** of the Sales Price of the
Transmission Product (if the Product is sold solely as a Transmission Product),
(ii) *** of the Sales Price of the Drivetrain Product (if the Product is sold solely as
a Drivetrain Product) and (iii) if the Product is a System Product, then either
(A) *** of the System Sales Price if such System Product is not covered by any of the
patents sold by Fallbrook to Manufacturer under the Patent Assignment Agreement, or (B) ***
if such System Product is covered by one or more of the patents sold by Fallbrook to
Manufacturer under the Patent Assignment Agreement;

 

			
	***	 	Portions of this page have been omitted
pursuant to a request for Confidential Treatment filed separately with the
Commission.

3

 

provided, however, that such royalty
shall not be due on any Sales Price or System Sales Price that is refunded to the applicable
customer; and

     (b) with respect to revenue and consideration received by Manufacturer or its
Affiliates or sublicensees from leases or other transactions regarding the Products (other
than the sale of Products described in Section (a) above), Manufacturer shall pay to
Fallbrook a royalty equal to the greater of (i) *** of such gross revenue and consideration,
and (ii) *** of the gross profit from such gross revenue and consideration (the
“gross profit” being calculated as the gross revenue and consideration less direct costs
that Manufacturer or its Affiliate or sublicensee actually incurs and that are directly
attributable to the specific revenue or consideration generating transaction).

     (c) Royalties owing on the sale of Products shall accrue on the date upon which the
applicable payment is invoiced by, or otherwise owing, Manufacturer its Affiliate or
sublicensee for such sale.

     (d) Royalties owing under Section 4.2(b) shall accrue when Manufacturer its Affiliate
or sublicensee receives payment for pertinent transactions.

     (e) Notwithstanding anything to the contrary in this Agreement, if pursuant to this
Agreement or any other agreement between Fallbrook and Viryd, Fallbrook supplies and sells
to Manufacturer any of Fallbrook’s continuously variable transmission products that
Manufacturer then further resells as a Transmission Product or as a component in a
Drivetrain Product or System Product, then no royalty shall be owing under this Agreement
with respect to the sale, lease or other revenues received for such Transmission Product,
Drivetrain Product or System Product.

     2.6 Sections 5.1 to 5.3. Sections 5.1 to 5.3 of the License Agreement are hereby
amended and restated in their entirety as follows:

     5.1 Development Efforts. Manufacturer shall use its best efforts to develop a
Product and after such development to promote, market and commercialize such Product. For
the avoidance of doubt, it shall not be a breach of the foregoing obligation if Manufacturer
devotes some portion of its resources to raising capital and for the development of
technology that will be incorporated into or otherwise supports the Product, Drivetrain
Product or System Product (e.g., wind blade technology).

     5.2 [RESERVED]

     5.3 Failure of Development Efforts. If Manufacturer fails to satisfy its
obligations under Section 5.1, then upon written notice from Fallbrook to Manufacturer,
Manufacturer shall have a period of ninety (90) days following such written notice to cure
any such failure or to provide Fallbrook with a plan for curing such failure that is
reasonably acceptable to Fallbrook in its sole good faith discretion. If Manufacturer is
unable to cure such failure and is unable to provide such an acceptable plan to Fallbrook
during such ninety (90) day period, or if after providing an acceptable plan to Fallbrook,

 

			
	***	 	Portions of this page have been omitted
pursuant to a request for Confidential Treatment filed separately with the
Commission.

4

 

Manufacturer materially fails to conduct the activities set forth in such plan, then as
Fallbrook’s sole and exclusive remedy for such failure, Fallbrook shall have the right to
convert the license grant under Section 3.1(a) of this Agreement from exclusive to
non-exclusive by written notice to Manufacturer.

     2.7 Section 8.2(a). Section 8.2(a) of the License Agreement is hereby amended to add
the following sentence to the end of the section.

     Notwithstanding the foregoing, if within six (6) months of receipt of written notice
from Manufacturer that a Third Party is making, using or selling a Product in the Field of
Use, Fallbrook fails to abate the infringement or file suit to enforce the Licensed Patents
against the infringing party in the Field of Use, then Manufacturer shall have the right to
take whatever action it deems appropriate in its own name or, if required by law for
standing purposes, in the name of Fallbrook to enforce the Licensed Patent in the Field of
Use. Manufacturer shall keep Fallbrook informed of the progress of such action and shall
reasonably accommodate any requests from Fallbrook regarding any such action. Additionally,
Fallbrook shall retain the right to join in any such action at its own expense.
Manufacturer may not settle, or otherwise consent to an adverse judgment in, any such action
that diminishes the rights or interests of Fallbrook without the prior express written
consent of Fallbrook. All monies recovered by Manufacturer upon the final judgment or
settlement of such action, after deducting costs and expenses for such action, shall be
deemed “Sales Price” and shall be subject to the royalty obligation in Section 4.2(a)(i).

     2.8 Section 9.1. Section 9.1 of the License Agreement is hereby amended and restated
in its entirety as follows:

     9.1 Expiration. Unless earlier terminated pursuant to Sections 5.3, 9.2 or
9.3, the term of this Agreement shall commence on the Effective Date of this Agreement and
shall continue until November 25, 2015 (the “Initial Term”). If, in the final year
of the Initial Term Manufacturer has retained exclusive rights under the license in
Section 3.1(a) and is continuing to develop and commercialize Products, then Manufacturer
shall have the right to extend the term of this Agreement by an additional seven (7) years
after expiration of the Initial Term (the “Renewal Term”) as follows. No less than
six (6) months prior to the expiration of the Initial Term, Manufacturer shall provide
Fallbrook with written notice of its intention to extend the term and a written report that
summarizes its progress in developing and commercializing Products, as well as its plans to
further develop and commercialize Products. Unless Fallbrook in good faith rejects the plan
as being commercially unreasonable within thirty (30) days after receipt by providing
written notice to Manufacturer, then upon payment of the Renewal Fee (as defined below) the
term of this Agreement shall continue until expiration of the Renewal Term. If Fallbrook
timely rejects such plan, then the parties shall meet in good faith for not less than
thirty (30) days and if the parties are unable to agree upon a revised plan, then the
parties shall submit to binding arbitration to determine whether Manufacturer has satisfied
its obligations under Section 5.1 and has provided a reasonable plan for the continued
development and commercialization of Products. The term of this Agreement shall continue
during any such arbitration proceeding and if the

5

 

arbitrator(s) finally conclude that
Manufacturer has satisfied its obligations under Section 5.1 and has provided a reasonable
plan for the continued development and commercialization of Products, then Manufacturer
shall have thirty (30) days to pay the Renewal Fee and the term of this Agreement shall
continue until expiration of the Renewal Term. As used herein “Renewal Fee” shall
mean the greater of (a) one half a percent (0.5%) of Manufacturer’s net revenues from
Products for the calendar year preceding the date of renewal, or (b) one hundred thousand
dollars ($100,000); provided, however, that the parties shall have the right to agree in
writing in advance on another amount.

3. Amendments to Assignment Agreement. The first sentence of Section 3.1 of the Assignment
Agreement is hereby deleted and replaced with the following sentences (the remainder of Section 3.1
shall remain unaffected):

     In consideration for the assignment of the Patents hereunder and other rights and
benefits set forth herein, until the expiration of the last to expire Patent, Viryd shall
pay to Fallbrook the following amounts with respect to any Product for which no royalty is
owing under the License Agreement and which does not constitute or contain a continuously
variable transmission that was supplied to Viryd by Fallbrook:
(a) *** of Net Sales of such Product by Viryd, its (sub)licensees and their respective
Affiliates, and (b) *** of Net Licensing Revenues. For the avoidance of
doubt, if Viryd pays to Fallbrook a royalty in accordance with the terms of the License
Agreement for a Product that is also covered under this Agreement (i.e., Viryd pays the full
*** royalty on the System Product in accordance with the terms of the License
Agreement), then no royalty shall be owing under this Agreement for such Product.

4. Amendments to Engineering Agreement.

     4.1 Section 2. Section 2 of the Engineering Agreement is amended to add the following
new sentences at the end thereof:

     Without limiting the generality of the foregoing, Fallbrook shall, at no cost to Viryd,
prepare and provide to Viryd no later than *** a pre-production design for a revised
28mm continuously variable transmission based on Fallbrook’s NuVinci technology as it exists
as of the Effective Date of the Master Agreement, or as otherwise mutually agreed upon by
the parties in writing. In addition, if Viryd provides an engineer to share the efforts
with a Fallbrook engineer, Fallbrook will additionally provide detail design part drawings
from the solid model design by such date. Until the expiration of this Agreement, if Viryd
requests any additional engineering support from Fallbrook, the fees
owing by Viryd for such support shall be mutually agreed upon but not to exceed
*** of Fallbrook’s fully burdened costs to provide such support.

5. Austin Facility. Until December 31, 2009, Fallbrook shall provide access to Viryd to
Fallbrook’s engineering facility located in Austin, Texas, and allow Viryd to conduct its

 

			
	*** 	 	Portions of this page have been omitted
pursuant to a request for Confidential Treatment filed separately with the
Commission.

6

 

engineering and development efforts at such facility, at no additional expense to Viryd. Viryd
shall have the right to allow potential customers and collaborators to tour such facility in order
to assess Viryd’s engineering and development efforts.

6. Recapitalization.

     6.1 Authorization of Class A Common Stock. Prior to the closing of the transactions
contemplated by that certain Stock Purchase Agreement by and among Fallbrook and the purchasers of
Series D Preferred Stock of Fallbrook set forth on Exhibit A thereto (the “Closing Date”), upon
receipt of the requisite Board of Directors and stockholder approvals, Viryd shall file with the
Delaware Secretary of State an Amended and Restated Certificate of Incorporation of Viryd in
substantially the form attached hereto as Exhibit A, which shall create and authorize a new
class of securities, Class A Common Stock of Viryd (“Class A Common Stock”).

     6.2 Conversion of Series A Preferred Stock to Class A Common Stock. Effective
immediately prior to the Closing Date, Fallbrook shall take all necessary steps to convert all
shares of Viryd Series A Preferred Stock held by Fallbrook (excluding shares of Viryd Series A
Preferred Stock being transferred to Fallbrook bridge note holders in consideration for
cancellation of warrants) into shares of Class A Common Stock.

7. Contribution of Common Stock to Viryd. Prior to the Closing Date, Fallbrook shall
transfer to Viryd, as a capital contribution, *** shares of Viryd Common Stock held
by Fallbrook and will take all other actions necessary or appropriate to effect such transaction.

8. Issuance of Viryd Common Stock to Fallbrook Employees. As soon as practicable after the
Effective Date, Viryd shall issue to certain Fallbrook employees an aggregate of *** shares of
Viryd Common Stock pursuant to Viryd’s 2008 Stock Plan in recognition for previously performed
consulting services. Such shares will be allocated to the Fallbrook employees in accordance with a
schedule and under certain restrictions provided by Fallbrook and approved by Viryd, which approval
shall not be unreasonably withheld.

9. General.

     9.1 Continuing Effect. Except as otherwise expressly modified by this Agreement, the
License Agreement, Assignment Agreement and Support Agreements shall each remain in full force and
effect in accordance with their terms.

     9.2 Governing Law. This Agreement is to be construed in accordance with and governed
by the internal laws of the State of California and/or U.S. federal law, if applicable, without
giving effect to any choice of law rule that would cause the application of the laws of any
jurisdiction other than the internal laws of the State of California and/or U.S. federal law,
if applicable, to the rights and duties of the parties.

     9.3 Attorneys’ Fees. If either party commences any action or proceeding against the
other party to enforce this Agreement or any of such party’s rights hereunder, the prevailing

 

			
	*** 	 	Portions of this page have been omitted
pursuant to a request for Confidential Treatment filed separately with the
Commission.

7

 

party
will be entitled to its reasonable expenses related to such action or proceeding, including
reasonable attorneys’ fees.

     9.4 No Waiver. No delay, failure or waiver by either party to exercise any right or
remedy under this Agreement, and no partial or single exercise of any such right or remedy, will
operate to limit, preclude, cancel, waive, or otherwise affect such right or remedy, nor will any
single or partial exercise of such right or remedy limit, preclude, impair, or waive any further
exercise of such right or remedy or the exercise of any other right or remedy.

     9.5 Severability. If any provision of this Agreement is determined to be invalid or
unenforceable, the validity or enforceability of the other provisions or of this Agreement as a
whole will not be affected; and, in such event, such provision will be changed and interpreted so
as best to accomplish the objectives of such provision within the limits of applicable law or
applicable court decision.

     9.6 Entire Agreement. This Agreement serves to document formally the entire
understanding between the parties relating to the subject matter hereof, and supersedes and
replaces any prior or contemporaneous agreements, negotiations, or understandings, whether oral or
written, relating to the same subject matter. No amendment or modification of any provision of
this Agreement will be effective unless in writing and signed by duly authorized signatories of
both parties.

     9.7 Counterparts. This Agreement may be executed in two (2) or more copies, each of
which shall be deemed an original, but all of which together shall constitute one and the same
instrument.

     In Witness Whereof, the parties have caused this Agreement to be executed by their duly
authorized representatives.

	 	 	 	 	 
	FALLBROOK TECHNOLOGIES INC.	 	 
	 
	 	 	 	 
	By: 

Title:

	 	/s/ William Klehm
 

President & CEO
	 	 
	Address:

	 	9444 Waples St., Suite 410

San Diego, CA 92121	 	 
	 
	 	 	 	 
	VIRYD TECHNOLOGIES INC.	 	 
	 
	 	 	 	 
	By: 

Title:

	 	/s/ Nicole Nicks
 

Chief Financial Officer
	 	 
	Address:

	 	9444 Waples St., Suite 410	 	 
	 

	 	San Diego, CA 92121	 	 

8

 

EXHIBIT A

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

OF

VIRYD TECHNOLOGIES INC.

     The undersigned, Gary L. Weiss, hereby certifies that:

     1. He is the duly elected CEO of Viryd Technologies Inc., a Delaware Corporation.

     2. The Certificate of Incorporation of this corporation was originally filed with the
Secretary of State of Delaware on January 3, 2007 under the name of Fallbrook Wind Technology Inc.

     3. The Certificate of Incorporation of this corporation shall read in full as follows:

ARTICLE I

     The name of this corporation is Viryd Technologies Inc. (the “Corporation”).

ARTICLE II

     The purpose of the Corporation is to engage in any lawful act or activity for which
corporations may be organized under the Delaware General Corporation Law.

ARTICLE III

     (A) Classes of Stock. The Corporation is authorized to issue three classes of stock
to be designated, respectively, “Common Stock,” “Class A Common Stock” and “Preferred Stock.” The
total number of shares which the Corporation is authorized to issue is Sixty Million (60,000,000)
shares, each with a par value of $0.001 per share. Thirty Million (30,000,000) shares shall be
Common Stock, Fifteen Million (15,000,000) shares shall be Class A Common Stock and Fifteen Million
(15,000,000) shares shall be Preferred Stock.

     (B) Rights, Preferences and Restrictions of Preferred Stock. The Preferred Stock
authorized by this Certificate of Incorporation (the “Certificate”) may be issued from time to time
in one or more series. The first series of Preferred Stock shall be designated “Series A
Preferred” and shall consist of Fourteen Million Nine Hundred Thousand (14,900,000) shares. The
rights, preferences, privileges, and restrictions granted to and imposed on the Series A Preferred
are as set forth below in this Article III(B). The Corporation’s Board of Directors (the “Board of
Directors”) is hereby authorized to fix or alter the rights, preferences, privileges and
restrictions granted to or imposed upon additional series of Preferred Stock, and the number of
shares constituting any such series and the designation thereof, or of any of them. Subject to
compliance with applicable protective voting rights which have been or may be granted to the
Preferred Stock or series thereof in Certificates of Determination or this Certificate of
Incorporation (“Protective Provisions”), but notwithstanding any other rights of the Preferred
Stock or any series thereof, the rights, privileges, preferences and restrictions of any such

1

 

additional series may be
subordinated to, pari passu with (including, without limitation, inclusion in
provisions with respect to liquidation and acquisition preferences, redemption and/or approval of
matters by vote or written consent), or senior to any of those of any present or future class or
series of Preferred Stock, Class A Common Stock or Common Stock. Subject to compliance with
applicable Protective Provisions, the Board of Directors is also authorized to increase or decrease
the number of shares of any series, prior or subsequent to the issue of that series, but not below
the number of shares of such series then outstanding. In case the number of shares of any series
shall be so decreased, the shares constituting such decrease shall resume the status which they had
prior to the adoption of the resolution originally fixing the number of shares of such series.

          1. Dividend Provisions. Subject to the rights of series of Preferred Stock which may
from time to time come into existence, other than dividends payable in Common Stock or other
securities and rights convertible into or entitling the holder thereof to receive, directly or
indirectly, additional shares of Common Stock, provided that an adjustment to the respective
Conversion Price (as defined below) of such other securities or rights has been made in accordance
with Section 4(d) of this Article III(B) below, no dividends shall be paid on any shares of the
Corporation’s capital stock unless an equal dividend per share is paid to the holders of the
Series A Preferred (on an as-if converted to Common Stock basis (following conversion of Class A
Common Stock issuable upon conversion of Series A Preferred pursuant to Section 4 of Article
III(C))).

          2. Liquidation.

               (a) Preferred Stock. In the event of any liquidation, dissolution or winding up of
the Corporation, either voluntary or involuntary, and subject to the rights of series of Preferred
Stock that may from time to time come into existence, the holders of the Series A Preferred shall
be entitled to receive, prior and in preference to any distribution of any of the assets of the
Corporation to the holders of Class A Common Stock or Common Stock by reason of their ownership
thereof, an amount per share equal to $1.00 per share (as adjusted for stock splits, stock
dividends, reclassification and the like with respect to such shares) for each share of Series A
Preferred then held by them, plus declared but unpaid dividends (collectively, the “Preferred
Preference”). If, upon the occurrence of such event, the assets and funds to be distributed among
the holders of the Series A Preferred shall be insufficient to permit the payment to such holders
of the full Preferred Preference, then, subject to the rights of series of Preferred Stock that may
from time to time come into existence, the entire assets and funds of the Corporation legally
available for distribution shall be distributed ratably among the holders of the Series A Preferred
in proportion to the preferential amount each such holder is otherwise entitled to receive pursuant
to this Section 2(a).

               (b) Class A Common Stock. Upon the completion of the distribution of the Preferred
Preference required by Section 2(a) of this Article III(B) above and any other distribution that
may be required with respect to series of Preferred Stock that may from time to time come into
existence, the holders of the Class A Common Stock shall be entitled to receive, prior and in
preference to any distribution of any of the assets of the Corporation to the holders of the Series
A Preferred (other than the Preferred Preference pursuant to Section 2(a) of this

2

 

Article III(B)
above) and the Common Stock by reason of their ownership thereof, an amount per share
equal to $1.00 per share (as adjusted for stock splits, stock dividends, reclassification and
the like with respect to such shares) for each share of Class A Common Stock then held by them,
plus declared but unpaid dividends (collectively, the “Class A Common Preference”). If, upon the
occurrence of such event, the assets and funds to be distributed among the holders of the Class A
Common Stock shall be insufficient to permit the payment to such holders of the full Class A Common
Preference, then, subject to the rights of series of Preferred Stock that may from time to time
come into existence, the entire assets and funds of the Corporation legally available for
distribution shall be distributed ratably among the holders of the Class A Common Stock in
proportion to the preferential amount each such holder is otherwise entitled to receive pursuant to
this Section 2(b).

               (c) Common Stock. Upon the completion of the distributions of the Preferred
Preference required by Section 2(a) of this Article III(B) above, the Class A Common Preference
required by Section 2(b) of this Article III(B) above and any other distribution that may be
required with respect to series of Preferred Stock that may from time to time come into existence,
the holders of the Common Stock shall be entitled to receive, prior and in preference to any
distribution of any of the assets of the Corporation to the holders of the Series A Preferred
(other than the Preferred Preference pursuant to Section 2(a) of this Article III(B) above) and the
Class A Common Stock (other than the Class A Common Preference pursuant to Section 2(b) of this
Article III(B) above) by reason of their ownership thereof, an amount of the remaining assets of
the Corporation available for distribution to stockholders equal to the sum of (i) the Preferred
Preference and (ii) the Class A Common Preference which shall be distributed among the holders of
Common Stock pro rata based on the number of shares of Common Stock held by each (the “Common
Preference”). If, upon the occurrence of such event, the assets and funds to be distributed among
the holders of the Common Stock shall be insufficient to permit the payment to such holders of the
full Common Preference, then, subject to the rights of series of Preferred Stock that may from time
to time come into existence, the entire assets and funds of the Corporation legally available for
distribution shall be distributed among the holders of the Common Stock pro rata based on the
number of shares of Common Stock held by each.

               (d) Preferred Stock. Upon the completion of the distributions of the Preferred
Preference required by Section 2(a) of this Article III(B) above, the Class A Common Preference
required by Section 2(b) of this Article III(B) above, the Common Preference required by Section
2(c) of this Article III(B) above and any other distribution that may be required with respect to
series of Preferred Stock that may from time to time come into existence, the holders of the Series
A Preferred shall be entitled to receive, prior and in preference to any distribution of any of the
assets of the Corporation to the holders of the Class A Common Stock (other than the Class A Common
Preference pursuant to Section 2(b) of this Article III(B) above) and the Common Stock (other than
the Common Preference pursuant to Section 2(c) of this Article III(B) above) by reason of their
ownership thereof, an amount of the remaining assets of the Corporation available for distribution
to stockholders equal to one-half of the Preferred Preference which shall be distributed among the
holders of Series A Preferred in proportion to the preferential amount each such holder received of
the Preferred Preference pursuant to Section 2(a) of this Article III(B) above (the “Secondary
Preferred Preference”). If, upon the occurrence of such event, the assets and funds to be
distributed among the holders of

3

 

the Series A Preferred shall be insufficient
to permit the payment to such holders of the full Secondary Preferred Preference, then,
subject to the rights of series of Preferred Stock that may from time to time come into existence,
the entire assets and funds of the Corporation legally available for distribution shall be
distributed among the holders of the Series A Preferred in proportion to the preferential amount
each such holder received of the Preferred Preference pursuant to Section 2(a) of this Article
III(B) above.

               (e) Class A Common Stock. Upon the completion of the distributions of the Preferred
Preference required by Section 2(a) of this Article III(B) above, the Class A Common Preference
required by Section 2(b) of this Article III(B) above, the Common Preference required by Section
2(c) of this Article III(B) above, the Secondary Preferred Preference required by Section 2(d) of
this Article III(B) above and any other distribution that may be required with respect to series of
Preferred Stock that may from time to time come into existence, the holders of the Class A Common
Stock shall be entitled to receive, prior and in preference to any distribution of any of the
assets of the Corporation to the holders of the Series A Preferred (other than the Preferred
Preference pursuant to Section 2(a) of this Article III(B) above and the Secondary Preferred
Preference pursuant to Section 2(d) of this Article III(B) above) and the Common Stock (other than
the Common Preference pursuant to Section 2(c) of this Article III(B) above) by reason of their
ownership thereof, an amount of the remaining assets of the Corporation available for distribution
to stockholders equal to one-half of the Class A Common Preference which shall be distributed among
the holders of Class A Common Stock in proportion to the preferential amount each such holder
received of the Class A Common Preference pursuant to Section 2(b) of this Article III(B) above
(the “Secondary Class A Common Preference”). If, upon the occurrence of such event, the assets and
funds to be distributed among the holders of the Class A Common Stock shall be insufficient to
permit the payment to such holders of the full Secondary Class A Common Preference, then, subject
to the rights of series of Preferred Stock that may from time to time come into existence, the
entire assets and funds of the Corporation legally available for distribution shall be distributed
among the holders of the Class A Common Stock in proportion to the preferential amount each such
holder received of the Class A Common Preference pursuant to Section 2(b) of this Article III(B)
above.

               (f) Remaining Assets. Upon the completion of the distributions of the Preferred
Preference required by Section 2(a) of this Article III(B) above, the Class A Common Preference
required by Section 2(b) of this Article III(B) above, the Common Preference required by Section
2(c) of this Article III(B) above, the Secondary Preferred Preference required by Section 2(d) of
this Article III(B) above, the Secondary Class A Common Preference required by Section 2(e) of this
Article III(B) above and any other distribution that may be required with respect to series of
Preferred Stock that may from time to time come into existence, the remaining assets of the
Corporation available for distribution to stockholders shall be distributed among the holders of
the Common Stock pro rata based on the number of shares of Common Stock held by each. For purposes
of this Section 2, each share of Series A Preferred, Class A Common Stock and Common Stock shall be
consistently treated solely as either Series A Preferred, Class A Common Stock or Common Stock.

4

 

               (g) Certain Acquisitions.

                    (i) Deemed Liquidation. For purposes of this Section 2, a liquidation, dissolution,
or winding up of the Corporation shall be deemed to occur if the Corporation shall sell, convey, or
otherwise dispose of all or substantially all of its property or business or merge with or into or
consolidate with any other corporation, limited liability company or other entity (other than a
wholly-owned subsidiary of the Corporation) (any such transaction, unless elected otherwise, an
“Acquisition”), provided, however, that none of the following shall be considered an Acquisition:
(i) a merger effected exclusively for the purpose of changing the domicile of the Corporation, (ii)
an equity financing in which the Corporation is the surviving corporation, or (iii) a transaction
in which the stockholders of the Corporation immediately prior to the transaction own 50% or more
of the voting stock of the surviving corporation following the transaction (taking into account
only stock of the Corporation held by such stockholders prior to the transaction).

                    (ii) Valuation of Consideration. In the event of a deemed liquidation as described in
Section 2(g)(i) of this Article III(B) above, if the consideration received by the Corporation is
other than cash, its value will be deemed its fair market value. Any securities shall be valued as
follows:

                         (A) Securities not subject to investment letter or other similar restrictions on free
marketability:

                              (1) If traded on a securities exchange or The Nasdaq Global Market (“Nasdaq”), the value shall
be based on the formula specified in the definitive agreements for the Acquisition or, if no such
formula exists, then the value of such securities shall be based on a formula approved by the Board
of Directors and derived from the closing prices of the securities on such exchange or Nasdaq over
a specified time period;

                              (2) If actively traded over-the-counter, the value shall be based on the formula specified in
the definitive agreements for the Acquisition or, if no such formula exists, then the value of such
securities shall be based on a formula approved by the Board of Directors and derived from the
closing bid or sales prices (whichever is applicable) of such securities over a specified time
period; and

                              (3) If there is no active public market, the value shall be the fair market value thereof, as
determined in good faith by the Board of Directors.

                         (B) The method of valuation of securities subject to investment letter or other restrictions
on free marketability (other than restrictions arising solely by virtue of a stockholder’s status
as an affiliate or former affiliate) shall be to make an appropriate discount from the market value
determined as specified above in Section 2(g)(ii)(A) of this Article III(B) to reflect the
approximate fair market value thereof, as determined in good faith by the Board of Directors.

                    (iii) Notice of Liquidation Transaction. The Corporation shall give each holder of
record of Preferred Stock written notice of any impending Acquisition

5

 

not later than 10 days prior
to the stockholders’ meeting called to approve such Acquisition, or 10 days prior to the closing of
such Acquisition, whichever is earlier, and shall also notify such holders in writing of the final
approval of such Acquisition. The first of such notices shall describe the material terms and
conditions of the impending Acquisition and the provisions of this Section 2, and the Corporation
shall thereafter give such holders prompt notice of any material changes. Unless such notice
requirements are waived, the Acquisition shall not take place sooner than 10 days after the
Corporation has given the first notice provided for herein or sooner than 10 days after the
Corporation has given notice of any material changes provided for herein. Notwithstanding the
other provisions of this Certificate, all notice periods or requirements in this Certificate may be
shortened or waived, either before or after the action for which notice is required, upon the
written consent of the holders of a majority of the outstanding shares of Preferred Stock that are
entitled to such notice rights

                    (iv) Effect of Noncompliance. In the event the requirements of this Section 2(g) are
not complied with, the Corporation shall forthwith either cause the closing of the Acquisition to
be postponed until the requirements of this Section 2 have been complied with, or cancel such
Acquisition, in which event the rights, preferences, privileges and restrictions of the holders of
Preferred Stock shall revert to and be the same as such rights, preferences, privileges and
restrictions existing immediately prior to the date of the first notice referred to in Section
2(g)(iii) of this Article III(B) above.

          3. Redemption. The Series A Preferred is not redeemable.

          4. Conversion. The holders of the Series A Preferred shall have conversion rights as
follows (the “Series A Conversion Rights”):

               (a) Right to Convert. Subject to Section 4(c), each share of Series A Preferred shall
be convertible, at the option of the holder thereof, at any time after the date of issuance of such
share, at the office of the Corporation or any transfer agent for such stock, into such number of
fully paid and non-assessable shares of Class A Common Stock as is determined by dividing $1.00 in
the case of the Series A Preferred by the Conversion Price applicable to such share, determined as
hereafter provided, in effect on the date the certificate is surrendered for conversion. The
initial Conversion Price per share shall be $1.00 for shares of Series A Preferred. Such initial
Conversion Price shall be subject to adjustment as set forth in Section 4(d) of this Article III(B)
below.

               (b) Automatic Conversion. Each share of Preferred Stock shall automatically be
converted into shares of Class A Common Stock at the Conversion Price at the time in effect for
such share immediately upon the earlier of (i) except as provided below in Section 4(c) of this
Article III(B), immediately prior to the automatic conversion of the underlying shares of Class A
Common Stock pursuant to Section 4(b) of Article III(C) below and the closing of the Corporation’s
sale of its Common Stock in a firm commitment underwritten public offering pursuant to a
registration statement under the Securities Act of 1933, as amended (the “Securities Act”), which
results in aggregate cash proceeds to the Corporation of at least $15,000,000 (net of
underwriting discounts and commissions) (a “Qualified IPO”) or (ii) the date specified by
written consent or agreement of the holders of a

6

 

majority of the then outstanding shares of
Preferred Stock, voting together as a single class on an as-if converted to Class A Common Stock
basis.

               (c) Mechanics of Conversion. Before any holder of Preferred Stock shall be entitled
to convert such Preferred Stock into shares of Class A Common Stock, the holder shall surrender the
certificate or certificates therefor, duly endorsed (or a reasonably acceptable affidavit and
indemnity undertaking in the case of a lost, stolen or destroyed certificate), at the office of the
Corporation or of any transfer agent for such series of Preferred Stock, and shall give written
notice to the Corporation at its principal corporate office, of the election to convert the same
and shall state therein the name or names in which the certificate or certificates for shares of
Class A Common Stock are to be issued. The Corporation shall, as soon as practicable thereafter,
issue and deliver at such office to such holder of Preferred Stock, or to the nominee or nominees
of such holder, a certificate or certificates for the number of shares of Class A Common Stock to
which such holder shall be entitled as aforesaid, and a certificate for the remaining number of
shares of Series A Preferred if less than all of the Series A Preferred evidenced by the
certificate were surrendered. Such conversion shall be deemed to have been made immediately prior
to the close of business on (i) the date of such surrender of the shares of such series of
Preferred Stock to be converted or (ii) if applicable, the date of automatic conversion specified
in Section 4(b) of this Article III(B) above, and the person or persons entitled to receive the
shares of Class A Common Stock issuable upon such conversion shall be treated for all purposes as
the record holder or holders of such shares of Class A Common Stock as of such date. If the
conversion is in connection with an underwritten public offering of securities registered pursuant
to the Securities Act the conversion may, at the option of any holder tendering such Preferred
Stock for conversion, be conditioned upon the closing with the underwriters of the sale of
securities pursuant to such offering, in which event any persons entitled to receive Class A Common
Stock upon conversion of such Preferred Stock shall not be deemed to have converted such Preferred
Stock until immediately prior to the conversion of the underlying shares of Class A Common Stock
pursuant to Section 4(b) of Article III(C) below and the closing of such sale of securities.

               (d) Conversion Price Adjustments of Preferred Stock for Certain Dilutive Issuances. The
Conversion Price of each of the Series A Preferred shall be subject to adjustment from time to time
if the Corporation should issue, at any time after the date upon which any shares of Series A
Preferred were first issued (the “Purchase Date”), any Additional Stock (as defined below) without
consideration or for a consideration per share less than the Conversion Price for such series in
effect immediately prior to the issuance of such Additional Stock, the Conversion Price for such
series in effect immediately prior to each such issuance shall automatically be adjusted as set
forth in this Section 4(d), unless otherwise provided in this Section 4(d).

                    (i) Adjustment Formula. Whenever the Conversion Price is adjusted pursuant to this
Section (4)(d), the new Conversion Price shall be determined by multiplying the Conversion Price
then in effect by a fraction, (X) the numerator of which shall be the number of shares of Common
Stock outstanding immediately prior to such issuance (the “Outstanding Common”) plus the number of
shares of Common Stock that the aggregate
consideration received by the Corporation for such issuance would purchase at such Conversion

7

 

Price; and (Y) the denominator of which shall be the number of shares of Outstanding Common plus
the number of shares of such Additional Stock. For purposes of the foregoing calculation, the term
“Outstanding Common” shall include shares of Common Stock deemed issued pursuant to Section 4(d)(v)
of this Article III(B) below.

                    (ii) Definition of “Additional Stock”. For purposes of this Section 4(d), “Additional
Stock” shall mean any shares of Common Stock issued (or deemed to have been issued pursuant to
Section 4(d)(v) of this Article III(B) below) by the Corporation after the Purchase Date) other
than

                         (A) Common Stock issued pursuant to stock dividends, stock splits or similar transactions, as
described in Section 4(d) of Article III(C);

                         (B) Common Stock issued or issuable to employees, officers, consultants or directors of the
Corporation, or other persons performing services for the Corporation, directly or pursuant to a
stock option plan or restricted stock plan approved by the Board of Directors;

                         (C) Capital stock, or options or warrants to purchase capital stock, issued to financial
institutions or lessors in connection with commercial credit arrangements, equipment financings,
commercial property lease transactions or similar transactions;

                         (D) Capital stock issuable upon exercise of warrants, notes, or other convertible securities
outstanding as of the date of this Certificate;

                         (E) Capital stock, or warrants or options to purchase capital stock, issued in connection with
bona fide acquisitions, mergers or similar transactions, the terms of which are approved by the
Board of Directors;

                         (F) Class A Common Stock issued upon conversion of the Series A Preferred;

                         (G) Common Stock issued upon conversion of the Class A Common Stock;

                         (H) Capital stock issued or issuable to an entity as a component of any business relationship
with such entity for the purpose of (1) joint venture, technology licensing or development
activities, (2) distribution, supply or manufacture of the Corporation’s products or services or
(3) any other arrangements involving corporate partners that are primarily for purposes other than
raising capital, the terms of which business relationship with such entity are approved by the
Board of Directors; and

                         (I) Capital stock issued or issuable with the affirmative vote of at least a majority of the
then outstanding shares of Series A Preferred voting as a separate class.

8

 

                    (iii) No Fractional Adjustments. No adjustment of the Conversion Price for any series
of Preferred Stock shall be made in an amount less than one cent per share, provided that any
adjustments which are not required to be made by reason of this sentence shall be carried forward
and shall be either taken into account in any subsequent adjustment made prior to three years from
the date of the event giving rise to the adjustment being carried forward, or shall be made at the
end of three years from the date of the event giving rise to the adjustment being carried forward.

                    (iv) Determination of Consideration. In the case of the issuance of Common Stock for
cash, the consideration shall be deemed to be the amount of cash paid therefor before deducting any
reasonable discounts, commissions or other expenses allowed, paid or incurred by the Corporation
for any underwriting or otherwise in connection with the issuance and sale thereof. In the case of
the issuance of the Common Stock for a consideration in whole or in part other than cash, the
consideration other than cash shall be deemed to be the fair value thereof as determined by the
Board of Directors irrespective of any accounting treatment.

                    (v) Deemed Issuances of Common Stock. In the case of the issuance (whether before, on
or after the applicable Purchase Date) of securities or rights convertible into, or entitling the
holder thereof to receive directly or indirectly, additional shares of Common Stock (the “Common
Stock Equivalents”), the following provisions shall apply for all purposes of this Section 4(d):

                         (A) The aggregate maximum number of shares of Common Stock deliverable upon conversion,
exchange or exercise (assuming the satisfaction of any conditions to convertibility,
exchangeability or exercisability, including, without limitation, the passage of time, but without
taking into account potential antidilution adjustments) of any Common Stock Equivalents and
subsequent conversion, exchange or exercise thereof shall be deemed to have been issued at the time
such securities were issued or such Common Stock Equivalents were issued and for a consideration
equal to the consideration, if any, received by the Corporation for any such securities and related
Common Stock Equivalents (excluding any cash received on account of accrued interest or accrued
dividends), plus the minimum additional consideration, if any, to be received by the Corporation
(without taking into account potential antidilution adjustments) upon the conversion, exchange or
exercise of any Common Stock Equivalents (the consideration in each case to be determined in the
manner provided in Section 4(d)(iv) of this Article III(B).

                         (B) In the event of any change in the number of shares of Common Stock deliverable or in the
consideration payable to the Corporation upon conversion, exchange or exercise of any Common Stock
Equivalents, other than a change resulting from the antidilution provisions thereof, the Conversion
Price of any series of Preferred Stock, to the extent in any way affected by or computed using such
Common Stock Equivalents, shall be recomputed to reflect such change, but no further adjustment
shall be made for the actual issuance of Common Stock or any payment of such consideration upon the
conversion, exchange or exercise of such Common Stock Equivalents.

9

 

                         (C) Upon the termination or expiration of the convertibility, exchangeability or
exercisability of any Common Stock Equivalents, the Conversion Price of any series of Preferred
Stock, to the extent in any way affected by or computed using such Common Stock Equivalents, shall
be recomputed to reflect the issuance of only the number of shares of Common Stock (and Common
Stock Equivalents that remain convertible, exchangeable or exercisable) actually issued upon the
conversion, exchange or exercise of such Common Stock Equivalents.

                         (D) The number of shares of Common Stock deemed issued and the consideration deemed paid
therefor pursuant to Section 4(d)(v)(A) shall be appropriately adjusted to reflect any change,
termination or expiration of the type described in either Section 4(d)(v)(B) or 4(d)(v)(C) of this
Article III(B) above.

                    (iv) No Increased Conversion Price. Notwithstanding any other provisions of this
Section (4)(d), except to the limited extent provided for in Sections 4(d)(v)(B) and 4(d)(v)(C) of
this Article III(B) above, no adjustment of the Conversion Price pursuant to this Section 4(d)
shall have the effect of increasing the Conversion Price above the Conversion Price in effect
immediately prior to such adjustment.

               (e) Other Distributions. In the event the Corporation shall declare a distribution
(other than a subdivision, combination or merger or sale of assets transaction provided for
elsewhere in this Section 4 or in Section 2 of this Article IV(B)) payable in securities of other
persons, evidences of indebtedness issued by the Corporation or other persons, assets (excluding
cash dividends) or options or rights not referred to in Section 4(d) of this Article III(B) above
or 4(d)(ii) of Article III(C) below, then, in each such case for the purpose of this Section 4(e),
the holders of each series of Preferred Stock shall be entitled to a proportionate share of any
such distribution as though they were the holders of the number of shares of Common Stock into
which their shares of Preferred Stock are eventually convertible (following conversion of Class A
Common Stock issuable upon conversion of Series A Preferred pursuant to Section 4 of Article
III(C)) as of the record date fixed for the determination of the holders of Common Stock entitled
to receive such distribution; provided, that no holder of Series A Preferred or Class A
Common Stock shall be entitled to any distribution pursuant to both this Section 4(e) and Section
4(e) of Article III(C) with respect to the same distribution.

               (f) No Impairment. The Corporation will not, through any reorganization,
recapitalization, transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms to be observed or performed hereunder by the Corporation, but will at all times in
good faith assist in the carrying out of all the provisions of this Section 4 and in the taking of
all such action as may be necessary or appropriate in order to protect the Series A Conversion
Rights of the holders of Preferred Stock against impairment.

               (g) No Fractional Shares and Certificate as to Adjustments.

                    (i) No fractional shares shall be issued upon the conversion of any share or shares of any
series of Preferred Stock, and the number of shares of Class A
Common Stock to be issued shall be rounded down to the nearest whole share. The number of

10

 

shares issuable upon such conversion shall be determined on the basis of the total number of shares
of any series of Preferred Stock the holder is at the time converting into Class A Common Stock and
the number of shares of Class A Common Stock issuable upon such aggregate conversion. If the
conversion would result in any fractional share, the Corporation shall, in lieu of issuing any such
fractional share, pay the holder thereof an amount in cash equal to the fair market value of such
fractional share on the date of conversion, as determined in good faith by the Board of Directors.

                    (ii) Upon the occurrence of each adjustment or readjustment of the Conversion Price of Series
A Preferred pursuant to this Section 4, the Corporation, at its expense, shall promptly compute
such adjustment or readjustment in accordance with the terms hereof and prepare and furnish to each
holder of such Preferred Stock a certificate setting forth such adjustment or readjustment and
showing in detail the facts upon which such adjustment or readjustment is based. The Corporation
shall, upon the written request at any time of any holder of Series A Preferred, furnish or cause
to be furnished to such holder a like certificate setting forth (A) such adjustment and
readjustment, (B) the Conversion Price for such series of Preferred Stock at the time in effect,
and (C) the number of shares of Class A Common Stock and the amount, if any, of other property
which at the time would be received upon the conversion of a share of such series of Preferred
Stock.

               (h) Notices of Record Date. In the event of any taking by the Corporation of a record
of the holders of any class of securities for the purpose of determining the holders thereof who
are entitled to receive any dividend (other than a cash dividend) or other distribution, any right
to subscribe for, purchase or otherwise acquire any shares of stock of any class or any other
securities or property, or to receive any other right, the Corporation shall mail to each holder of
Series A Preferred, at least 10 days prior to the date specified therein, a notice specifying the
date on which any such record is to be taken for the purpose of such dividend, distribution or
right, and the amount and character of such dividend, distribution or right.

               (i) Reservation of Stock Issuable Upon Conversion. The Corporation shall at all times
reserve and keep available out of its authorized but unissued shares of Class A Common Stock,
solely for the purpose of effecting the conversion of the shares of the Series A Preferred, such
number of its shares of Class A Common Stock as shall from time to time be sufficient to effect the
conversion of all outstanding shares of such series of Preferred Stock; and if at any time the
number of authorized but unissued shares of Class A Common Stock shall not be sufficient to effect
the conversion of all then outstanding shares of such series of Preferred Stock, in addition to
such other remedies as shall be available to the holder of such Preferred Stock, the Corporation
will take such corporate action as may, in the opinion of its counsel, be necessary to increase its
authorized but unissued shares of Class A Common Stock to such number of shares as shall be
sufficient for such purposes, including, without limitation, engaging in best efforts to obtain the
requisite stockholder approval of any necessary amendment to this Certificate.

               (j) Notices. Any notice required by the provisions of this Section 4 to be given to
the holders of shares of Preferred Stock shall be deemed given if deposited in the

11

 

United States mail, postage prepaid, and addressed to each holder of record at his address
appearing on the books of the Corporation.

          5. Voting Rights. Except as expressly provided by this Certificate or as provided by
law, the holders of Series A Preferred shall have the same voting rights as the holders of Common
Stock and shall be entitled to notice of any stockholders’ meeting in accordance with the Bylaws of
the Corporation, as such may be amended from time to time (the “Bylaws”), and the holders of Common
Stock, Class A Common Stock and Series A Preferred shall vote together as a single class on all
matters. Each holder of Common Stock shall be entitled to one vote for each share of Common Stock
held, and each holder of Series A Preferred shall be entitled to the number of votes equal to the
number of shares of Common Stock into which such shares of Series A Preferred could eventually be
converted (following conversion of Class A Common Stock issuable upon conversion of Series A
Preferred pursuant to Section 4 of Article III(C)). Fractional votes shall not, however, be
permitted and any fractional voting rights available on an as-if converted to Class A Common Stock
basis (after aggregating all shares into which shares of Series A Preferred by each holder could be
converted) shall be rounded to the nearest whole number (with one-half being rounded upward).

          6. Protective Provisions. Subject to the rights of series of Preferred Stock which
may from time to time come into existence, so long as at least 1,000,000 shares of Series A
Preferred are outstanding (as adjusted for stock splits, stock dividends, reclassification and the
like with respect to such shares), the Corporation shall not (by amendment, merger, consolidation
or otherwise) without first obtaining the approval (by vote or written consent, as provided by law)
of the holders of at least a majority of the then outstanding shares of Series A Preferred, voting
as a separate class:

               (a) alter or change the rights, preferences or privileges of the shares of Series A Preferred
so as to affect adversely the shares of the class;

               (b) increase or decrease (other than by conversion) the total number of authorized shares of
Common Stock or Preferred Stock;

               (c) increase or decrease (other than by conversion) the total number of authorized shares of
Series A Preferred; or

               (d) authorize or issue, or obligate itself to issue, any other equity security, including any
security (other than Series A Preferred) convertible into or exercisable for any equity security,
having a preference over the Series A Preferred with respect to voting, dividends, redemption,
conversion or upon liquidation.

          7. Status of Converted Stock. In the event any shares of Preferred Stock shall be
converted pursuant to Section 4 of Article III(B) above, the shares so converted shall be cancelled
and shall not be issuable by the Corporation. This Certificate shall be appropriately amended to
effect the corresponding reduction in the Corporation’s authorized capital stock.

12

 

     (C) Class A Common Stock.

          1. Dividend Rights. Subject to the rights of series of Preferred Stock which may from
time to time come into existence, other than dividends payable in Common Stock or other securities
and rights convertible into or entitling the holder thereof to receive, directly or indirectly,
additional shares of Common Stock, no dividends shall be paid on any shares of Common Stock unless
an equal dividend per share is paid to the holders of the Class A Common Stock (on an as-if
converted to Common Stock basis).

          2. Liquidation Rights. Upon the liquidation, dissolution or winding up of the
Corporation or the occurrence of a Liquidation Transaction, the assets of the Corporation shall be
distributed as provided in Section 2 of Article III(B).

          3. Redemption. The Class A Common Stock is not redeemable.

          4. Conversion. The holders of the Class A Common Stock shall have conversion rights
as follows (the “Class A Conversion Rights”):

               (a) Right to Convert. Subject to Section 4(c) of this Article III(C) below, each
share of Class A Common Stock shall be convertible, at the option of the holder thereof, at any
time after the date of issuance of such share, at the office of the Corporation or any transfer
agent for such stock, into such number of fully paid and non-assessable shares of Class A Common
Stock as is determined by dividing $1.00 in the case of the Class A Common Stock by the Conversion
Price applicable to such share, determined as hereafter provided, in effect on the date the
certificate is surrendered for conversion. The initial Conversion Price per share shall be $1.00
for shares of Class A Common Stock. Such initial Conversion Price shall be subject to adjustment
as set forth in Section 4(d) of this Article III(C) below.

               (b) Automatic Conversion. Each share of Class A Common Stock shall automatically be
converted into shares of Common Stock at the Conversion Price at the time in effect for such share
immediately upon the earlier of (i) except as provided below in Section 4(c) of this Article
III(C), immediately subsequent to an automatic conversion of the Series A Preferred into Class A
Common Stock pursuant to Section 4(b)(i) of Article III(B) and prior to the closing of the
Corporation’s sale of its Common Stock in a Qualified IPO or (ii) the date specified by written
consent or agreement of the holders of a majority of the then outstanding shares of Class A Common
Stock, voting as a separate class on an as-if converted to Common Stock basis.

               (c) Mechanics of Conversion. Before any holder of Class A Common Stock shall be
entitled to convert such Class A Common Stock into shares of Common Stock, the holder shall
surrender the certificate or certificates therefor, duly endorsed (or a reasonably acceptable
affidavit and indemnity undertaking in the case of a lost, stolen or destroyed certificate), at the
office of the Corporation or of any transfer agent for the Class A Common Stock, and shall give
written notice to the Corporation at its principal corporate office, of the election to convert the
same and shall state therein the name or names in which the certificate or certificates for shares
of Common Stock are to be issued. The Corporation shall, as soon as
practicable thereafter, issue and deliver at such office to such holder of Class A Common

13

 

Stock, or to the nominee or nominees of such holder, a certificate or certificates for the number
of shares of Common Stock to which such holder shall be entitled as aforesaid, and a certificate
for the remaining number of shares of Class A Common Stock if less than all of the Class A Common
Stock evidenced by the certificate were surrendered. Such conversion shall be deemed to have been
made immediately prior to the close of business on (i) the date of such surrender of the shares of
Class A Common Stock to be converted or (ii) if applicable, the date of automatic conversion
specified in Section 4(b) of this Article III(C) above, and the person or persons entitled to
receive the shares of Common Stock issuable upon such conversion shall be treated for all purposes
as the record holder or holders of such shares of Common Stock as of such date. If the conversion
is in connection with an underwritten public offering of securities registered pursuant to the
Securities Act the conversion may, at the option of any holder tendering such Class A Common Stock
for conversion, be conditioned upon the closing with the underwriters of the sale of securities
pursuant to such offering, in which event any persons entitled to receive Common Stock upon
conversion of such Class A Common Stock shall not be deemed to have converted such Class A Common
Stock until immediately prior to the closing of such sale of securities.

               (d) Conversion Price Adjustments for Certain Splits and Combinations. The Conversion
Price of each of the Class A Common Stock shall be subject to adjustment from time to time as
follows:

                    (i) Stock Splits and Dividends. In the event the Corporation should at any time after
the Purchase Date fix a record date for the effectuation of a split or subdivision of the
outstanding shares of Common Stock or the determination of holders of Common Stock entitled to
receive a dividend or other distribution payable in additional shares of Common Stock or Common
Stock Equivalents without payment of any consideration by such holder for the additional shares of
Common Stock or the Common Stock Equivalents (including the additional shares of Common Stock
issuable upon conversion or exercise thereof), then, as of such record date (or the date of such
dividend distribution, split or subdivision if no record date is fixed), the Conversion Price of
the Class A Common Stock shall be appropriately decreased so that the number of shares of Common
Stock issuable on conversion of each share shall be increased in proportion to such increase of the
aggregate of shares of Common Stock outstanding.

                    (ii) Reverse Stock Splits. If the number of shares of Common Stock outstanding at any
time after the Purchase Date is decreased by a combination of the outstanding shares of Common
Stock, then, following the record date of such combination, the Conversion Price for the Class A
Common Stock shall be appropriately increased so that the number of shares of Common Stock issuable
on conversion of each share of such series shall be decreased in proportion to such decrease in
outstanding shares.

               (e) Other Distributions. In the event the Corporation shall declare a distribution
(other than a subdivision, combination or merger or sale of assets transaction provided for
elsewhere in this Section 4 or in Section 2 of Article III(B)) payable in securities of other
persons, evidences of indebtedness issued by the Corporation or other persons, assets
(excluding cash dividends) or options, then, in each such case for the purpose of this Section

14

 

4(e), the holders of Class A Common Stock shall be entitled to a proportionate share of any such
distribution as though they were the holders of the number of shares of Common Stock into which
their shares of Class A Common Stock are convertible as of the record date fixed for the
determination of the holders of Common Stock entitled to receive such distribution;
provided, that no holder of Series A Preferred or Class A Common Stock shall be entitled to
any distribution pursuant to both Section 4(e) of Article III(B) and this Section 4(e) with respect
to the same distribution.

               (f) Recapitalizations. If at any time or from time to time there shall be a
recapitalization of the Common Stock (other than a subdivision, combination or merger or sale of
assets transaction provided for elsewhere in this Section 4 or in Section 2 of Article III(B))
provision shall be made so that the holders of Class A Common Stock shall thereafter be entitled to
receive upon conversion of such Class A Common Stock the number of shares of stock or other
securities or property of the Corporation or otherwise, to which a holder of Common Stock
deliverable upon conversion would have been entitled on such recapitalization. In any such case,
appropriate adjustment shall be made in the application of the provisions of this Section 4 with
respect to the rights of the holders of Class A Common Stock after the recapitalization to the end
that the provisions of this Section 4 (including adjustment of the Conversion Price then in effect
and the number of shares purchasable upon conversion of such Class A Common Stock) shall be
applicable after that event and be as nearly equivalent as practicable.

               (g) No Impairment. The Corporation will not, through any reorganization,
recapitalization, transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms to be observed or performed hereunder by the Corporation, but will at all times in
good faith assist in the carrying out of all the provisions of this Section 4 and in the taking of
all such action as may be necessary or appropriate in order to protect the Class A Common
Conversion Rights of the holders of Class A Common Stock against impairment.

               (h) No Fractional Shares and Certificate as to Adjustments.

                    (i) No fractional shares shall be issued upon the conversion of any share or shares of any
Class A Common Stock and the number of shares of Common Stock to be issued shall be rounded down to
the nearest whole share. The number of shares issuable upon such conversion shall be determined on
the basis of the total number of shares of Class A Common Stock the holder is at the time
converting into Common Stock and the number of shares of Common Stock issuable upon such aggregate
conversion. If the conversion would result in any fractional share, the Corporation shall, in lieu
of issuing any such fractional share, pay the holder thereof an amount in cash equal to the fair
market value of such fractional share on the date of conversion, as determined in good faith by the
Board of Directors.

                    (ii) Upon the occurrence of each adjustment or readjustment of the Conversion Price of Class A
Common Stock pursuant to this Section 4, the Corporation, at its expense, shall promptly compute
such adjustment or readjustment in accordance with the terms hereof and prepare and furnish to each
holder of Class A Common Stock a certificate setting forth
such adjustment or readjustment and showing in detail the facts upon which such

15

 

adjustment or
readjustment is based. The Corporation shall, upon the written request at any time of any holder
of Class A Common Stock, furnish or cause to be furnished to such holder a like certificate
setting forth (A) such adjustment and readjustment, (B) the Conversion Price for the Class A Common
Stock at the time in effect, and (C) the number of shares of Common Stock and the amount, if any,
of other property which at the time would be received upon the conversion of a share of Class A
Common Stock.

               (i) Notices of Record Date. In the event of any taking by the Corporation of a record
of the holders of any class of securities for the purpose of determining the holders thereof who
are entitled to receive any dividend (other than a cash dividend) or other distribution, any right
to subscribe for, purchase or otherwise acquire any shares of stock of any class or any other
securities or property, or to receive any other right, the Corporation shall mail to each holder of
Class A Common Stock, at least 10 days prior to the date specified therein, a notice specifying the
date on which any such record is to be taken for the purpose of such dividend, distribution or
right, and the amount and character of such dividend, distribution or right.

               (j) Reservation of Stock Issuable Upon Conversion. The Corporation shall at all times
reserve and keep available out of its authorized but unissued shares of Common Stock, solely for
the purpose of effecting the conversion of the shares of the Class A Common Stock, such number of
its shares of Common Stock as shall from time to time be sufficient to effect the conversion of all
outstanding shares of Class A Common Stock; and if at any time the number of authorized but
unissued shares of Common Stock shall not be sufficient to effect the conversion of all then
outstanding shares of Class A Common Stock, in addition to such other remedies as shall be
available to the holder of Class A Common Stock, the Corporation will take such corporate action as
may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of
Common Stock to such number of shares as shall be sufficient for such purposes, including, without
limitation, engaging in best efforts to obtain the requisite stockholder approval of any necessary
amendment to this Certificate.

               (k) Notices. Any notice required by the provisions of this Section 4 to be given to
the holders of shares of Class A Common Stock shall be deemed given if deposited in the United
States mail, postage prepaid, and addressed to each holder of record at his address appearing on
the books of the Corporation.

          5. Voting Rights. Except as expressly provided by this Certificate or as provided by
law, the holders of Class A Common Stock shall have the same voting rights as the holders of Common
Stock and shall be entitled to notice of any stockholders’ meeting in accordance with the Bylaws,
and the holders of Common Stock, Class A Common Stock and Series A Preferred shall vote together as
a single class on all matters. Each holder of Common Stock shall be entitled to one vote for each
share of Common Stock held, and each holder of Class A Common Stock shall be entitled to the number
of votes equal to the number of shares of Common Stock into which such shares of Class A Common
Stock could be converted. Fractional votes shall not, however, be permitted and any fractional
voting rights available on an as-if converted to Common Stock basis (after aggregating all shares
into which shares of Class A

16

 

Common Stock by each holder could be converted) shall be rounded to the nearest whole number
(with one-half being rounded upward).

          6. Protective Provisions. So long as any shares of Class A Common Stock are
outstanding, the Corporation shall not (by amendment, merger, consolidation or otherwise) without
first obtaining the approval (by vote or written consent, as provided by law) of the holders of at
least a majority of the then outstanding shares of the Class A Common Stock, voting as a separate
class alter or change the rights, preferences or privileges of the shares of Class A Common Stock
so as to affect adversely the shares of the class.

          7. Status of Converted Stock. In the event any shares of Class A Common Stock shall
be converted pursuant to Section 4 of this Article III(C) above, the shares so converted shall be
cancelled and shall not be issuable by the Corporation. This Certificate shall be appropriately
amended to effect the corresponding reduction in the Corporation’s authorized capital stock.

     (D) Common Stock.

          1. Dividend Rights. Subject to the prior rights of holders of all classes of stock at
the time outstanding having prior rights as to dividends, the holders of the Common Stock shall be
entitled to receive, when and as declared by the Board of Directors, out of any assets of the
Corporation legally available therefor, such dividends as may be declared from time to time by the
Board of Directors.

          2. Liquidation Rights. Upon the liquidation, dissolution or winding up of the
Corporation or the occurrence of a Liquidation Transaction, the assets of the Corporation shall be
distributed as provided in Section 2 of Article III(B).

          3. Redemption. The Common Stock is not redeemable.

          4. Voting Rights. Each holder of Common Stock shall have the right to one vote per
share of Common Stock, and shall be entitled to notice of any stockholders’ meeting in accordance
with the Bylaws, and shall be entitled to vote upon such matters and in such manner as may be
provided by law.

ARTICLE IV

     The Board of Directors is expressly authorized to make, alter or repeal Bylaws.

ARTICLE V

     Elections of directors need not be by written ballot unless otherwise provided in the Bylaws.

ARTICLE VI

     (A) To the fullest extent permitted by the Delaware General Corporation Law, as the same
exists or as may hereafter be amended, a director of the Corporation shall not be personally

17

 

liable
to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a
director.

     (B) The Corporation shall indemnify to the fullest extent permitted by law any person made or
threatened to be made a party to an action or proceeding, whether criminal, civil, administrative
or investigative, by reason of the fact that he, his testator or intestate is or was a director or
officer of the Corporation or any predecessor of the Corporation, or serves or served at any other
enterprise as a director or officer at the request of the Corporation or any predecessor to the
Corporation.

     (C) Neither any amendment nor repeal of this Article VI, nor the adoption of any provision of
the Corporation’s Certificate of Incorporation inconsistent with this Article VI, shall eliminate
or reduce the effect of this Article VI in respect of any matter occurring, or any action or
proceeding accruing or arising or that, but for this Article VI, would accrue or arise, prior to
such amendment, repeal or adoption of an inconsistent provision.

* * *

18

 

     The foregoing Certificate of Incorporation has been duly adopted by this corporation’s Board
of Directors and stockholders in accordance with the applicable provisions of Sections 228, 242,
and 245 of the Delaware General Corporation Law.

     Executed at San Diego, California, on [                    ], 2008.

	 	 	 	 	 
	 	 	 
	 	  	
 	 
	 	 	Gary L. Weiss, CEO 	 
	 	 	 	 
	 

19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00168-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00168-of-00352.parquet"}]]